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ABSTRACT
MAJOR HISTOCOMPATIBILITY COMPLEX (MHC) VS.
NON-MHC INFLUENCES ON RESPONSE TO 
RSV-INDUCED TUMORS IN CHICKENS
by
DAVID W. BROWN 
University of New Hampshire, Septemb
The MHC of the chicken (B complex) has 
exert a decisive influence on the fate of Ro 
(RSV)-induced tumors. However, noninbred ch 
identical B genotypes and inbred lines indis 
the MHC have demonstrated considerable varia 
to RSV challenge. The major objective of th 
to determine the cause of variation in anti­
response observed among chickens with "ident 
g e n o t y p e s .
Chickens were evaluated for anti-tumor 
following wingweb inoculation with RSV at si 
A comparison of anti-sarcoma responses of (1 
versus (151-5 X 7-2)F1 chickens revealed rapid regression 
among the (151-5 X 6-1)F1's and tumor progression among the 
(151-5 X 7-2)F1*s. A three way cross between (151-5 X 
6-3)F1's and line 7-2 produced B.2/B2 and B2/B15 progeny. 
B2/B15 chickens from this cross, identical at the B complex
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x weeks of age. 
51-5 X 6-1)F 1
to the (151-5 X 7-2)F1 progressors, were characterized by- 
tumor regression. Therefore a non-MHC influence associated 
with the line 7-2 background appeared to suppress 
anti-sarcoma response.
Similar findings were obtained using F2 and backcross 
progeny of lines 100 and UNH 105, low response being 
associated with the line 100 background. Both lines 7-2 and 
100 are susceptible to M a r e k ’s disease (MD). Histological 
evidence for MD involvement was obtained from bursal 
sections of chickens that had died of progressive sarcoma 
growth. It is postulated that low anti-sarcoma response 
associated with MD susceptible lines may result from 
environmental exposure to MD and subsequent 
immunosuppression in spite of vaccination for MD at 
hatching. If low anti-sarcoma response associated with 
lines 100 and 7-2 is a result of immunosuppression by MD 
virus, then non-MHC genetic background would appear to be a 
strong factor influencing relative susceptibility to M D .
x i
I. T. N T-R ODUCTION
A better understanding of the basic mechanisms involved 
in disease resistance can clearly aid in disease control and 
in the selection process for disease resistant plants and 
animals. Genes within the major histocompatibility complex 
(MHC), a tightly linked cluster of genes found in vertebrate 
species, exert a profound influence on host response to 
disease. Genetic studies dealing with the MHC of the mouse 
have proved of great value in providing insight into the 
mechanisms of the immune response of both man and animals.
A fairly consistent characteristic of the immune 
response has been its high degree of specificity. An MHC 
haplotype characterized by low response to a particular 
antigen can often respond well to other antigens. Because 
of such specificity, selection for resistance to one 
particular disease has the inherent danger of rendering a 
population susceptible to another disease or to a variant of 
the disease used for selection.
In natural populations of different species, the MHC 
has been found to be highly polymorphic. MHC polymorphism 
would clearly help protect a species from extermination by 
one of the many potential disease agents in the environment. 
Use of the MHC alone as a basis of selection for disease 
resistance could undermine such broad based protection by 
causing the loss of potentially valuable MHC haplotypes.
2Knowledge of non-MHC genetic factors influencing resistance 
to specific diseases could prove useful in preventing such a 
l o s s .
The MHC of the chicken (B complex) has been shown to 
exert a decisive influence on the fate of RSV-induced 
sarcomas. Inbred chicken lines with indistinguishable 
(either serologically or by functional assays) B. haplotypes, 
however, have varied considerably in their anti-Rous sarcoma 
responses. Indistinguishable is clearly not synonomous with 
identical, and the observed variation between lines in 
anti-tumor response could have resulted from either 
undetected variation within the MHC or to non-MHC influences 
(genetic and/or environmental). The major objective of the 
research discussed in this dissertation was to determine the 
cause of variation in anti-Rous sarcoma response observed 
among chickens with indistinguishable S. genotypes.
II. REVIEW OF THE LITERATURE
The Ma.ior Histocompatibility Complex
The major histocompatibility complex (MHC) is a tightly
linked cluster of genes responsible for various
immunological phenomena including the regulation of 
cell-mediated and humoral immunity. Originally discovered 
in mice as the major cause of rapid rejection of 
incompatible neoplastic and normal tissue grafts (Counce &t 
a l . 1 956), the MHC was subsequently found to play a major 
role in the regulation of immune responses to a wide variety 
of insults including synthetic polypeptides (McDevitt and 
Chinitz 1969, Benacerraf and McDevitt 1972) and more 
naturally encountered pathogens (Lilly 1968, Zinkernagel and 
Doherty 1975). The evolutionary significance of the MHC can 
be appreciated by fact of its presence in every mammalian
species studied to date as well as its presence in
non-mammalian vertebrates such as birds and bony fish (Klein 
1977)•
The MHC has been most thoroughly characterized in the 
mouse. Known as the H-2 complex in this species, it is 
currently divided into at least five regions - K, I, S, G, 
and D (Golub 1977, Benacerraf 1981). The K and D regions 
code for membrane bound glycoproteins found on nearly all 
cell surfaces but in highest concentrations on macrophages
and mature T and B lymphocytes (Klein 1977). These 
glycoproteins are the major stimulus for graft rejection and 
are key recognition elements involved in the intercellular 
cooperation required for generation of cytotoxic responses 
(Doherty et. al. 1976). Arbitrarily designated as class I 
molecules, the products of the K and D regions are 
noncovalently associated with a smaller polypeptide, b_eta 
2-microglobulin, encoded by a non-MHC gene (Klein 1977).
The I region codes for I associated (la) antigens.
These glycoproteins, designated as class II antigens, are 
also found on cell surfaces. The distribution, however, is 
limited primarily to macrophages and B cells (Benacerraf 
1981). Suppressor T cells bear antigens encoded by one
particular subregion, I-J (Murphy at al. 1976), and soluble
factors involved in regulation of immune response also bear 
la antigens (Benacerraf and Germain 1978). Immune response 
(I r ) genes, which control responses to a variety of 
thymus-dependent antigens, have been postulated to code for 
the la antigens. Alternatively, it has been suggested that 
Ir genes are primarily expressed on T cells and are involved 
in the production of specific helper and suppressor factors
bearing determinants encoded by loci in the I-A and I-J
subregions, respectively (Benacerraf and Unanue 1979).
There is an increasing amount of evidence in support of the 
former hypothesis. Antisera directed against la antigens 
block T cell responses to antigens under ££. gene control 
(Schwartz et. al.. 1 976 ). No recombinant animals have been
5found that separate i a  loci and ic. loci from the same 
subregion of the I region (Fathman e£ ai. 1981), and 
complementing ir. gene phenomena have been found to coincide 
with complementing I_a loci (Schwartz e£ a l . 1978).,
The G region codes for erythrocyte alloantigens 
(Schwartz 1980). Its functional significance has not been 
clearly determined. The S region codes for some components 
of the complement system (Carroll and Capra 1978). This 
system, consisting tentatively of 17 serum globulins, is 
involved in the humoral portion of the inflammatory response 
(Benacerraf and Unanue 1979). Sequential activation via a 
process of limited enzymatic proteolysis can lead to lysis 
of the target cell or, perhaps more importantly, to 
lymphokine production, chemotaxis of inflammatory cells, and 
enhanced opsonization.
The human MHC (HLA) is divided into four regions - D,
B, C, and A. HLA-A, B, and C antigens correspond both 
structurally and functionally to the mouse K and D gene 
products (Benacerraf and Unanue 1979). HLA-D appears to be 
the human counterpart of H-2I of the mouse (Albert and Gotze 
1977). In addition to the class I and II type antigens, 
several complement components (class III antigens) are 
associated with HLA (Benacerraf and Unanue 1979).
The B. blood group system of the chicken was discovered 
by Briles .et. al. ( 1950) and shown to be a marker for the MHC 
by Schierman and Nordskog (196 1). The B. complex is located 
on a medium-sized microchromosome that also contains the
6nucleolar organizer (Bloom .et. 1 978). It is currently 
divided into three regions, B - F . B - L . and B-G (Hala si. 
a l . 1 977 , Pink et. al,. 1 977). Recombinants have been found 
which separate B-G from the B-F and B-L regions (Briles and 
Briles 1977, Hala et. a l . 1976), but recombinations between 
B-L and B-F have not been identified with certainty 
(Longenecker and Mosmann 1981).
The B-F region codes for surface antigens on most cells 
including leukocytes and erythrocytes. These glycoproteins 
are associated with beta 2-microglobulin-like molecules and 
may be analogous to the H2-K and H2-D products of mice 
(Ziegler and Pink 1975). B-L gene products may be analogous 
to la antigens of mice as judged by their occurrence 
exclusively on immunoglobulin-positive lymphocytes and 
monocytes/macrophages (Ewert and Cooper 1978, Crone s i  
a l . 1981). The B-G region codes for erythrocyte surface 
antigens which may be involved in differentiation of cells 
of the erythroid series (Longenecker and Mossman 1981). 
Although no immunological function has been attributed to 
the B-G region, Hala et. sJL« (1981) recently reported that 
B-G antigen appeared to play a decisive role in the 
induction of humoral immunity against allogeneic B-F antigen 
on erythrocytes.
Like H-2 and HLA, the MHC of the chicken appears to 
influence serum complement levels (Chanh si. al- 1976). 
Reports of immunological regulation associated with the £  
complex include responses to synthetic polypeptides (Gunther
7et a l . 1974, Benedict et. aJL. 1975) and to virus-induced 
neoplasms (Longenecker it ai. 1976 , Briles .§£ ai* 19 7 7 » 
Collins et. aJL. 1977 » Schierman ei. si. 1977). The B complex 
has also been associated with autoimmune disease (Bacon and 
Rose 1979).
The RNA Tumor Viruses
History
In 1908 Ellerman and Bang reported the transmission of 
erythromyeloblastic leukemia of chickens by cell-free 
filtrates of leukemia cells (Tooze 1973). The first 
transmission of a solid tumor (a sarcoma of chickens) by 
cell-free filtrates was reported three years later by Rous 
(1911). Bittner (1936) obtained the first evidence that a 
mouse mammary gland carcinoma is transmitted from mother to 
offspring via a factor in the milk. This factor was later 
identified as a filterable virus (Andervont and Bryan 1944). 
Gross (1951) successfully transmitted leukemia to mice by 
inoculating with extracts of leukemia cells from a strain of 
mice with a high incidence of spontaneous leukemia. Since 
that time, several strains of murine leukemia viruses have 
been isolated, including the Friend, Moloney, Rauscher, and 
Graffi strains, and murine sarcoma viruses have also been 
identified (Tooze 1973). RNA tumor viruses have been 
incriminated as the cause of leukemlas and/or sarcomas in a 
wide variety of different animal species including cats
8(Jarrett et. al.. 1 964), cattle (Kettman js£ 1 976 ), and
most recently, man (Lewin 1981, Robert-Guroff .gi &X. 1982).
Pathology
Neoplasms are classified according to their tissue of 
origin. Carcinomas, for example, are malignant tumors of 
epithelial origin, whereas sarcomas are malignant tumors 
originating in connective tissue. Neoplasms of the 
hemopoietic and reticulo-endothelial systems may consist of 
solid masses of tumor cells or be characterized by leukemia, 
the circulation of large numbers of malignant cells. RNA 
tumor viruses are classified into three major groups: 
sarcoma, acute leukemia, and lymphoid leukosis viruses, on 
the basis of their pathogenicity in infected animals 
(Hanafusa 1981). Rous sarcoma virus causes rapid 
transformation of fibroblasts within 5-10 days after 
infection. Avian lymphoid leukosis viruses cause 
transformation of lymphoid cells of the bursa of Fabricius 
and have a latency period of several months. Acute leukemia 
viruses, in contrast, cause transformation of lymphoid cells 
of the bone marrow within 1-3 weeks after infection 
(Hanafusa 1981).
Mechanisms of transmission
Transmission of avian RNA tumor viruses can occur by 
several routes. Horizontal infection with leukosis viruses 
typically results in a transient viremia, immunity, and
9rarely leukosis. Vertical transmission includes congenital 
infection and genetic transmission. Congenital infections 
are strictly maternal and result in chronic viremia and the 
frequent occurrence of leukosis (Rubin a l . 1962).
Both horizontal and congenital infections involve 
exogenous avian leukosis viruses (ALV's). Genetic 
transmission involves endogenous viruses which are 
integrated in the gametic DNA and are inherited as part of 
the chicken genome.
Relationship between avian sarcoma and leukosis viruses
The genomes of avian leukosis viruses contain three 
defined genes: gag coding for internal viral structural 
proteins, pol for the virion RNA-directed DNA polymerase 
(reverse transcriptase), and env for virion envelope 
glycoproteins (Coffin 1979). A fourth region, £., may 
contain promoter sequences (Robinson e_t al. 1 980). The 
genetic structure of the lymphoid leukosis virus genome is 
in the order 5 ' -ga g - Pol- env- c - 3 1.
The avian sarcoma virus genome includes the src gene. 
The src gene product is a protein kinase with the unique 
ability to phosphorylate tyrosine residues of substrate 
proteins rather than serine or threonine residues, sites of 
phosphorylation for most known cellular protein kinases 
(Hunter and Sefton 1980). Since phosphorylation of proteins 
is associated with cell regulation, the increased level of 
phosphorylating activity by the src protein may trigger the
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transformation process (Hanafusa 1981). Sequences in the 
normal avian genome have a high degree of homology with the 
src gene (Stehelin e£ aJL. 1 976 ), and it is currently 
postulated that the sarcoma viruses as well as acute 
leukemia viruses arose from the recombinational events 
between leukosis viruses and the cellular genome of the host 
(Hanafusa 1981). Nondefective avian sarcoma viruses such as 
the Schmidt-Ruppin and Prague strains of Rous sarcoma virus 
(RSV) contain the entire genome of the avian leukosis 
viruses with the addition of the src gene inserted between 
env and c. (5 ^ g a g -p o l - env- src-c-^ 1) . Defective sarcoma 
viruses and the acute leukemia viruses are lacking portions 
of the ALV genome and require coinfection with an ALV for 
replication (Hanafusa 1981). In the case of the Bryan high 
titer strain of RSV (BH-RSV), the env gene is missing. Env 
gene products supplied by the coinfecting "Rous associated 
virus'* (RAV) determine the subgroup specificity of the 
sarcoma virus resulting from such phenotypic mixing. 
Endogenous viruses which contain the env gene can also aid 
in the replication of the defective Bryan strain. Such 
endogenous env gene products were originally referred to as 
chick helper factor (chf) for their ability to aid in 
replication of BH-RSV in the absence of exogenous helper 
virus (Tooze 1973)*
Cellular resistance to infection
Avian leukosis and sarcoma viruses have been classified
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into subgroups on the basis of their host range in chickens. 
Susceptibility of a cell to infection appears to depend on 
the presence of receptor sites specific for viruses of each 
subgroup (Crittenden and Briles 1971). The plating 
efficiency of virus on resistant cells is 1/1000 or less the 
efficiency of plating on susceptible cells (Tooze 1973) • 
Virus particles adsorb to both resistant and susceptible 
cells, but penetrate only susceptible ones (Crittenden 
1968). Subgroup specificity is determined by the virus 
envelope glycoproteins (products of the env gene of leukosis 
or nondefective sarcoma v i r u s e s ) . Viruses of the same 
subgroup have the ability to interfere with each other, 
presumably by blocking the receptor sites. Leukosis 
virus-infected cells become resistant to infection with 
sarcoma viruses of the same subgroup, and such interference 
has been exploited as an assay of leukosis virus infection 
(Vogt and Ishizaki 1966).
Genetic Resistance to Avian Virus-Induced Tumors
Marek's disease
Hanson et. al. (1967) suggested that the B21 haplotype 
conferred a higher level of resistance to Marek's disease 
(MD) than another B haplotype, B 19 • Pazderka e_fc. &JL • ( 1975) 
found that Cole's line N (Cole 1968), selected for 
resistance to M D , was uniformly homozygous for B21, while 
line P, selected in parallel for susceptibility, was
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segregating for three or four other B haplotypes. The 
association of the B21 haplotype with resistance to MD was 
clearly demonstrated in experiments using F1 backcross 
(Briles et. al. 1 977) and F2 progenies (Longenecker .§£ 
a l . 1 976) segregating at the MHC. Several B haplotypes have 
been more or less categorized according to degree of MD 
resistance. .B21 exhibits strong resistance; R2 and 1.6, 
moderate resistance. B5 , B1 3 , and B 15 are associated with 
high levels of susceptibility (Longenecker and Mosmann 
1 9 8 1).
Non-MHC influences on MD resistance have also been 
implicated. RPRL inbred lines 6 and 7 are homozygous for 
the B2 haplotype. Line 6 is resistant to M D , whereas line 7 
is susceptible. The 1  haplotypes of the two lines are 
indistinguishable either serologically or by functional 
assays (Pazderka et. aJL. 1 975). Fredericksen aJL. ( 1977) 
reported that Ly-4, a T-cell antigen of chickens, may 
influence relative susceptibility to M D . The different Ly-4 
genotypes tested were produced from separate sets of 
non-inbred dams. Therefore other influences (both genetic 
and environmental) could have been the source of the 
observed variation.
Different isolates of MD virus vary greatly in their 
pathogenicity, both in terms of virulence and in their 
characteristic lesions (Powell 1981). Some highly virulent 
strains of MD virus have recently been described against 
which vaccination provides only partial protection (Witter
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S i  si. 1980).
RSV-induced sarcomas
1kg. fi_Qgjrpi e£
Gyles and Brown (1971) demonstrated that the incidence 
of regression of RSV-induced sarcomas could be modified 
significantly by selection. Collins s i  si* (1977)» using 
(6-1 X 15-1 )F2 chickens segregating for three £. genotypes, 
observed a strong influence of B genotype on ability to 
respond to B H - R S V (R A V - 1) induced sarcomas. The percentages 
by genotype of a total of 376 B2/B2, B2/B5, and B5/B5 - 
chickens dying of tumor by ten weeks postinoculation were 5, 
26, and 93, respectively. The relative influences of sex, D 
genotype, and I genotype were considered insignificant since 
chi square values for the respective distributions of 
chickens to tumor profile index (TPI, an index of anti-tumor 
response) had associated probabilities greater than 0.01. 
However, all three calculated chi square values (i.g,. for 
sex, D. and X  genotypes) had associated probabilities of less 
than 0.05. Subsequent hatches (Collins, unpublished data) 
indicated that the effects of sex and D. genotype were 
insignificant. The X  locus appeared to have a very subtle 
influence, if any.
The regressive potential associated with the B2 
haplotype appeared to be strongly influenced by 
environmental conditions (Collins £t. kL. 1977). One hatch 
totalling 109 chickens, not included among the 376 described
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above, apparently was exposed to some undefined 
environmental insult which resulted in sporadic cases of 
"aplastic anemia". The percentages of these J32/B2, B2/B5, 
and B5/B.5 chickens dying of tumor by ten weeks PI were 61, 
77, and 97, respectively. Clearly an environmental variable 
existed which severely suppressed anti-tumor response.
.B genotype appeared to influence the frequency of 
metastasis, since B5/B5 chickens which died of terminal 
tumors had a greater frequency of gross metastatic lesions 
(61$) than either B2/B2 (27$) or B2/B5 (23$) hosts (Collins 
et a l . 1977). However, 80$ of all B.2/B.2 and 55$ of all 
B2/B5 chickens with terminal tumors were from hatches 
containing birds dying with aplastic anemia. The low 
incidence of metastasis associated with these two B. 
genotypes may therefore have been indicative of another 
complicating factor which precipitated death prior to 
development of gross metastatic lesions.
Schierman et. aJL. (1977) found a similar association 
between B genotype and ability to regress Schmidt-Ruppin 
(subgroup B) RSV-induced tumors using inbred lines G-B1 and 
G-B2 and crosses of these lines. G-B1 and G-B2 are 
homozygous for the B.13 and B6 haplotypes, respectively 
(Briles and Briles 1981). Among 90 backcross progeny from 
F1 females mated to a G-B1 male, 96$ of B13/B13 chickens 
developed progressive tumor growth compared to only 8$ of 
the heterozygous JB genotype B6/B13. Their interpretation of 
these results was that RSV-induced tumor regression was
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controlled by a dominant gene for regression linked to the 
MHC. Results from progeny of B6/B13 heterozygous parents 
did not support such an interpretation, since nearly half of 
B6/B.6 and B.6/B13 progeny were progressors. Such results 
were tentatively attributed to possible recombination within 
the MHC, but non-MHC influences (genetic and/or 
environmental) could adequately and perhaps more plausibly 
explain the observed within genotype variation. No 
serological evidence was cited to indicate recombination.
Use of B complex recombinants has provided evidence 
that the B - F /B-L portion of the MHC is involved in 
regression of RSV-induced tumors (Collins and Briles 1981, 
Auclair ai. 1981).
Non-MHC influences
A possible non-MHC genetic influence on regression of 
RSV-induced tumors was reported by Marks a£. aJL* ( 1979).
RPRL inbred lines 6-1, 6-3, and 7-2 (all homozygous for the 
B2 haplotype) were used to produce F 1 t F2, and reciprocal 
backcross progenies. Lines 6-1 and 6-3 were intermingled as 
a source of "line 6". Seventy-four % of (6 X 7-2)F1 X 7-2 
backcross progeny were characterized by progressive tumor 
growth following challenge with B H - R S V ( R A V - 1). In contrast, 
only 6% of (6 X 7-2)F1 X 6 backcross progeny were 
progressors. (6 X 7-2)F2 chickens had a tumor progression 
incidence of 60%. A similar study (Marks ai. al* 1 979) using 
BH-RSV(RAV-49) instead of B H - R S V ( R A V - 1) for challenge did 
not yield such dramatic differences. Reciprocal backcrosses
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of (6-3 X 7-2)F 1 chickens to line 6-3 were characterized by 
a 3$ incidence of progressive tumor growth. Corresponding 
hackcrosses to line 7-2 resulted in a 14$ incidence of tumor 
progression. Although these results suggested non-MHC 
influences (either genetic, environmental, or both), they 
did not rule out a possible undetected difference between 
the B haplotypes of line 7-2 and lines 6-3 and 6-1.
Lv-4 and T h - 1 . Gilmour, Collins and others (manuscript 
submitted) have suggested that T lymphocyte alloantigens 
Ly-4 and Th-1 influence regression of Rous sarcomas. In one 
experiment using (6-3 X 7-2)F4 chickens, a Ly-4 X Th-1 
interaction appeared to have a significant influence on 
response to B H - R S V ( R A V - 1 )-induced tumors. Chickens having 
the Ly-4 and Th-1 genotypes characteristic of line 7-2 had a 
high frequency of regression. Thus Ly-4 and Th-1 influences 
would not explain the high incidence of progression reported 
by Marks et. al.. ( 1979). In a second experiment using (6-3 X 
7-2)F5 chickens, Ly-4 appeared to significantly influence 
response and the Ly-4 X Th-1 interaction was not significant 
(P > 0.05). Again, chickens having the Ly-4 and Th-1 
genotypes of line 7-2 had a high incidence of regression.
In both experiments, separate sets of noninbred dams 
produced each of the Ly-4/Th-1 genotype combinations. Thus 
other influences (genetic and/or environmental) could have 
been major sources of variation. Assuming that F2, F4, and 
F5 generations of the cross would have similar incidences of 
tumor regression, the lower responses of (6 X 7-2)F2
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chickens reported by Marks .et. aJL. ( 1979) could indicate an 
environmental variable capable of suppressing response.
The L l o c u s . Collins (unpublished data) used (6-3 X 
100) F2 chickens segregating at the C, D, E, JE, and L. 
alloantigen loci to investigate the possible influence of 
these loci on Rous sarcoma regression. The C., D., JS, and X  
loci appeared to have no significant effect on response to 
RSV-1 induced sarcomas. The X  locus appeared to have some 
influence on tumor regression in females. Some F1 dams were 
homozygous at the L. locus resulting in unequal distribution 
of L. genotypes to progeny of various dams. Such could have 
resulted in maternal influences on responses associated with 
different L. genotypes. The relatively high incidence of 
progression among chickens containing the high responding £.2 
haplotype of line 6-3 and the presence of progeny resistant 
to tumor induction might suggest that some chickens were 
congenitally infected with avian leukosis virus. Progeny 
were not vaccinated for M D , so variations in maternal 
antibody could have been another important maternal 
i n f l u e n c e .
Endogenous v i r u s e s . The endogenous avian leukosis 
viruses could conceivably influence susceptibility to 
neoplasia in at least two ways. They could be the actual 
agents of cell transformation, or they could tolerize the 
animal to cross reacting antigens associated with a closely 
related oncogenic exogenous virus. Endogenous A L V ’s, when 
introduced into chickens as exogenous infections, do not
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appear to cause disease (Motta e£ sJL. 1975). However, 
recombination of a defective exogenous virus with an 
endogenous virus can result in an infective virus (Hanafusa 
et al. 1 970). Robinson e£ al.. ( 1 980) demonstrated that
recombinant viruses that contained the g a g . p o l , and env
\
genes of endogenous viruses and the c. region of exogenous 
viruses caused a similar incidence of disease as exogenous 
virus R A V - 1 . These findings suggested that the differences 
in oncogenic potential between endogenous and exogenous 
A L V ’s resided in the c. region. It was postulated that the s. 
region contained promoter sequences which, upon insertion 
into the host genome, caused expression of adjacent cellular 
genes as well as the viral genome. The failure of 
nondefective endogenous viruses to induce transformation may 
therefore reflect an inefficient endogenous promoter.
Halpern and Friis (1978) reported that endogenous viral 
genes influence the ability of the chicken to respond to the 
envelope glycoproteins of the related avian sarcoma virus. 
Chickens which are chick helper factor (chf) positive have 
endogenous viral genes causing expression of envelope 
glycoproteins of subgroup E specificity in the avian 
leukosis/sarcoma group. Sera from chf (+) chickens bearing 
subgroup A sarcomas had only marginal levels of 
group-specific reactivity to viral envelope glycoproteins in 
comparison to sera from chf (-) tumor bearing birds. The 
subgroup-specific reactivity in both groups was strong. The 
group specific determinants of the endogenous virus appeared
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to induce a tolerant state in chf (+) chickens or, 
alternatively, resulted in binding of group specific 
reactive antibodies in the blood. In support of Halpern and 
F r i i s ’ findings, Crittenden (personal communication) has 
indicated that chickens without detectable loci are 
characterized .by higher than average antibody responses 
following challenge with exogenous avian leukosis virus.
RPRL inbred lines 6-1 and 6-3 are homozygous for e v - 3 . 
a locus coding for a defective endogenous virus expressing 
envelope glycoproteins (Astrin e£. si. 1979). Both lines are 
characterized by a high incidence of regression of 
B H - R S V ( R A V - 1)-induced sarcomas (Collins si* 1980). In 
light of the findings of Halpern and Friis, there are at 
least two plausible explanations for the observed high 
responses. The cell-mediated portion of the immune system 
might not have become tolerized to group specific 
determinants of the envelope glycoproteins. Alternatively, 
the B2 haplotype of these lines may be responding to 
envelope determinants lacking on the endogenous products or 
possibly to a group specific non-virion antigen (Wainberg ^t 
a l . 1979a) associated with cells infected with nondefective
v i r u s .
RPRL inbred lines 7-2 and 100 contain e v - 2 . an 
endogenous virus locus which codes for the nondefective 
subgroup E virus, RAV-0 (Astrin jlL nl. 1980). These 
chickens conceivably could be tolerant not only to c h f , but 
also to a non-virion transformation-independent antigen
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associated with virus-infected cells. Wainberg ,§_t 
a l . (1979a) suggested that such an antigen was the major
stimulus in a peripheral lymphocyte stimulation assay using 
lymphocytes from chickens bearing RSV-induced tumors.
Results of Hall et. si* ( 1979) » hovever, implicated virus 
envelope antigens as the major target of immune reactivity 
during the primary response to RSV-induced tumors. (6-3 X 
7-2)F1 chickens, which also contain e v - 2 . are characterized 
by a fairly high incidence of regression of RSV-induced 
tumors (Marks et. si. 1979). Therefore, endogenous viruses 
probably have little effect if any on anti-Rous sarcoma 
responses of chickens carrying the B2 haplotype. It is 
conceivable, however, that other ]3 haplotypes with different 
specificities may be influenced by endogenous ALV's.
E nvironmental Factors Influencing Rous 
Sarcoma Regression
Age
A number of environmental variables have been shown to 
have strong influences on Rous sarcoma regression. With 
increase in age of host at time of infection, there is a 
higher frequency of regression and a lower frequency of 
metastasis (Freire et. al. 1953, Cotter sJL. 1 97 3» 
Heinzelmann et. ^1., 1981a). In young chickens, a
functionally immature immune system could clearly result in 
progressive tumor growth. Differences observed between
21
adult and six week old chickens in anti-sarcoma response, 
however, may reflect previous exposures to the closely 
related avian leukosis virus (Meyers ei. ai.. 1972) or another 
cross-reacting antigen such as reticuloendotheliosis virus 
(Baxter-Gabbard ai. aJL* 1 980).
Diet
Diet has also been shown to influence tumor 
development. Little .efc. al. (1948) demonstrated that 
development of Rous sarcoma could be completely prevented by 
maintaining chickens on a synthetic, folic acid free diet 
from the time of inoculation with virus. Treatment with 
folic acid antagonists produced similar results. The 
phenomenon was most apparent with very young chicks 
suggesting a direct nutritional effect on the tumor cells 
rather than a stimulus to the immune system. Clark (1980) 
demonstrated that protein-calorie restriction retarded 
growth of RSV-induced tumors. Restriction in tumor 
development and growth was thought to result from a limited 
supply of nutrients to the cancer cells.
Stres s
There is accumulating evidence that stress, either 
psychological or physical, may significantly affect an 
individual's immune system. Mice, for example, under 
stressful conditions, survived for shorter periods of time 
than non-stressed controls when challenged with a leukemia
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virus (Levine and Cohen 1959)* Rats experiencing 
inescapable shock had a lower incidence of tumor rejection 
than controls following challenge with a sarcoma tumor 
preparation (Visintainer et. aJL. 1 982). Available evidence 
suggests that stress-induced immunosuppression is mediated 
through the action of cortisone upon lymphocytes (Monjan and 
Collector 1 97T » Eskola .et. al.. 1 978). Corticosteroids 
administered in. vitro (Fauci and Dale 1974) suppress the 
response of lymphocytes to stimulation by mitogens and 
antigens. In addition, corticosteroids induce a decrease in 
the absolute numbers of circulating B and T lymphocytes, but 
the T-cell lymphopenia is more pronounced. It is likely 
that such is due to a redistribution of cells out of the 
circulation into other body components (Fauci and Dale 
1974).
Virus dosage and type
Virus dosage can clearly influence host response to 
RSV-induced tumors. High dilutions of "live" RSV have been 
successfully used for immunization against subsequent 
challenge with higher concentrations of the same virus 
(Sigel e£ gl.. 1971). Viruses of different subgroups 
(McBride et, aJL. 1981) and even different isolates of the 
same strain of virus (Cutting a£. aJL* 1981) demonstrate 
different potentials for progressive growth within a 
particular inbred line of chickens.
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Avian leukosis virus
Rubin (1962) reported that chickens congenitally
«
infected with avian leukosis virus required much higher 
concentrations of RSV to reach a tumor inducing end point 
than non-infected controls. When concentrations of RSV used 
to inoculate controls and ALV infected chickens were 
adjusted so that comparisons could be made on the basis of 
the biologically effective dosage of RSV administered, ALV 
congenitally infected birds invariably developed progressive 
tumor growth whereas tumors of controls tended to regress. 
Meyers and Qualtiere (1977) challenged normal chickens and 
chickens congenitally infected with a subgroup A ALV with 
strains of RSV from two different antigenic subgroups (B and 
C). Congenital ALV infection had no influence either on 
incidence or latency period of RSV-induced sarcomas, since 
the challenge viruses were not of the same subgroup as the 
ALV used for inducing congenital infection. Most tumors in 
RSV-challenged normal birds regressed, whereas tumors in 
ALV-infected birds grew progressively.
Use of ALV for immunization rather than tolerization 
resulted in resistance against RSV-induced tumors of the 
same or of different subgroups (Meyers ji£ &!• 1972). The 
protective effect was not dependent on neutralizing 
antibody, since chickens resistant to challenge had 
antibodies against only the immunizing virus and not against 
the heterologous challenge virus. Thus, depending on time 
of exposure, during embryological development or during the
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immunocompetent stage of postnatal life, avian leukosis 
virus can either inhibit or enhance response against the 
closely related Rous sarcoma viruses.
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tumorigenesis in chickens exposed by contact to MD virus. 
Since both ALV (Sharma 1979) and MD (Purchase jl£ al. 1968, 
Evans et. al. 1971) are immunosuppressive, coincident 
exposure to both viruses could have conceivably resulted in 
a synergistic immunosuppressive effect allowing 
tumorigenesis to occur in the LSI-SPF chickens.
MD causes a necrotizing infection which may severely 
affect both the bursa and thymus (Jakowski al* 1970) and 
subsequent ability to perform bursa and thymus dependent 
functions. Biggs et. aJL. ( 1968) found that infection with MD 
virus increased the susceptibility of Rhode Island Red 
chickens to coccidial infection. Calnek a i  al* (1975) 
subsequently demonstrated that MD exposure and development 
of gross lesions of MD resulted in an increased incidence of 
tumor progression following challenge with RSV.
Infectious bursal disease (IBD) is a viral disease of 
poultry with a global distribution. The virus causes 
destruction of lymphocytes, particularly in the bursa of 
Fabricius but also in the thymus, spleen, and caecal tonsils 
(Baxendale 1981). Immunosuppression resulting from 
subclinical IBD infection can result in both increased 
susceptibility to other diseases (Rosenberger and Gelb 1978, 
Wyeth 1975), as well as poor responses to vaccines 
(Giambrone ejt aJL. 1976).
Reticuloendothelosis virus (REV) is a C-type retrovirus 
unrelated to viruses of the avian leukosis-sarcoma group 
(Purchase et. aJL. 1 973). Originally isolated from a turkey
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(Theilen et. al.. 1 966), it has subsequently been found as a 
contaminant of HVT (MD) vaccines (Koyama si. al. 1976). REV 
infection results in a runting syndrome with severe atrophy 
of the bursa and thymus (Mussman and Twiehaus 1971). Bulow 
(1977) demonstrated that REV contamination markedly reduced 
the efficacy of MD vaccines, and Witter si. Si* ( 1979) found 
that the immunosuppressive effects of REV varied with the 
strain of virus and antigen studied.
Under conditions in which immunosuppressive infectious 
agents such as M D , ALV, and IBD are present, the potential 
of a sizable environmental influence on a chicken's 
anti-tumor response, or on responses to other insults such 
as synthetic polypeptides and bacterial antigens, is clearly 
evident. The possible involvement of uncontrolled 
environmental factors should be considered in interpretting 
what appear to be either MHC or non-MHC genetic influences 
on immune responses.
III. M A T E R I A L S  AND M E T H O D S
Animals
Information concerning B and ]S haplotypes, cellular 
susceptibility to avian leukosis viruses, susceptibility to 
Marek's disease and degree of inbreeding for each of the 
eight different genetic stocks of chickens used in this 
research is given in Table 1 (pg. 28). Lines 6 subline 1 
(6-1), 6 subline 3 (6 — 3)> 7 subline 2 (7-2), 100, 15 subline
1 (15-1), and 151 subline 5 (151-5) are inbred White Leghorn 
lines developed and maintained at the Regional Poultry 
Research Laboratory (RPRL), East Lansing, Michigan. Line 
UNH 105 is a noninbred line of New Hampshires originally 
obtained from a commercial breeder and maintained at the 
University of New Hampshire. Line K28, a noninbred White 
Leghorn line bred for susceptibility to subgroup E viruses, 
was provided by Harriet Robinson of the Worcester Foundation 
for Experimental Biology (WFEB), Shrewsbury, Mass.
Various crosses of the above lines resulted in 
segregation for alleles at several different blood group 
alloantigen loci. Typing to identify particular £, and in 
some cases E. alloantigen genotypes was performed in the 
laboratory of W.E. Briles, Department of Biological 
Sciences, Northern Illinois University, DeKalb, Illinois. 
Chickens were blood typed after two weeks of age (usually at
SLT a b l e  1 .  C h a r a c t e r i s t i c s  o f  c h i c k e n  l i n e s  u s e d  f o r  g e n e r a t i o n  o f  d a t a
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four weeks) by using a panel of alloantisera and classifying 
according to the patterns of reactivity obtained (Briles ,§£ 
&1. 1950).
Cane fif Animals
At hatching, chicks were wing-banded in the right 
wingweb, dubbed, and vaccinated subcutaneously with 0.2 ml 
of Marek's disease vaccine (cell free live turkey 
herpesvirus of chicken tissue culture origin, Sterwin 
Laboratories Inc., Millsboro, Delaware). During times of 
increased mortality due to a recurrent respiratory problem 
at the UNH Poultry Research Farm, chicks received 0.2 mg of 
gentamicin sulfate mixed with the Marek's vaccine. At 10 
days of age, chickens received Newcastle-bronchitis vaccine 
(live virus of chicken embryo origin; B1 type, B1 strain - 
Mass. and Conn. types; Sterwin Laboratories Inc.) in the 
drinking water. At three weeks of age, infectious bursal 
disease (IBD) vaccine (live virus, chicken tissue culture 
origin, Agri-Bio Corp., Gainesville, Ga.) was administered 
in the drinking water. UNH 105 line chickens used to 
characterize six B genotypes for anti-Rous sarcoma response 
did not receive the IBD vaccine.
Chickens were brooded from hatching to six weeks of age 
in conventional, electrically-heated brooding batteries in 
windowless rooms at the UNH Poultry Research Farm. At six 
weeks of age, experimental animals were moved to
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semi-isolated facilities for virus inoculation where they 
were maintained in holding batteries until termination of 
the experiment.
Breeder replacements, in addition to the above 
vaccination schedule, received Newcastle-bronchitis vaccine 
(live virus of chicken embryo origin; B1 type, La Sota 
strain - Mass. type; Sterwin Laboratories Inc.) in the 
drinking water at six weeks and again at 14 to 17 weeks of 
age. Breeders also received, via drinking water, Mycoplasma 
gallisepticum (live bacterium, F strain, grown in broth 
culture at UNH) and vaccine for avian encephalomyelitis 
(live virus, chicken embryo origin, Sterwin Laboratories 
Inc.) at 14 to 17 weeks of age.
Experimental chickens were fed, .ad. l i b i t u m , 
commercially prepared chick starter feed medicated with 
0.004? amprolium and bacitracin methylene disalicylate. 
Breeder replacements were fed the starter feed until 17 to 
20 weeks of age when they were transferred to special mating 
pens or breeder cages. At this time they were placed on a 
layer feed.
Viruses
The various RNA tumor viruses used and some of their 
characteristics are listed in Table 2. Avian leukosis 
virus, RAV-1 (subgroup A) and Bryan High-titer Rous sarcoma 
viruses of subgroups A, B, and C [(BH- R S V (R A V - 1),
T a b l e  2 .  C h a r a c t e r i s t i c s  o f  v i r u s e s  u s e d  i n  t h e  v a r i o u s  e x p e r i m e n t s .
V i r u s A b b r e v i a t i o n S u b g r o u p 3, P a t h o l o g y 3, T r a n s m i s s i o n 3,
BH-RSV ( R A V - 1 ) R S V -1 A s a r c o m a e x o g e n o u s
BH-RSV ( R A V - 2 ) R S V -2 B s a r c o m a e x o g e n o u s
BH-RSV ( R A V - 4 9 ) R S V - 4 9 C s a r c o m a e x o g e n o u s
RAV-1 RAV-1 A l e u k o s i s e x o g e n o u s
RAV-0 RAV-0 E " n o n o n c o g e n i c " e n d o g e n o u s
a T o o z e  1 9 7 3 .
y.
M o t t a  e t  a l . 1 9 7 5 ,  P u r c h a s e  e t  a l .  1 9 7 7 ,  C r i t t e n d e n  e t  a l .  1 9 7 9 .
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B H - R S V (R A V - 2 ), and B H - R S V ( R A V - M 9)» respectively)] were 
supplied by L.B. Crittenden (RPRL) BH-RSV is a defective 
virus requiring the aid of an avian leukosis virus (ALV) for 
production of an envelope. Subgroup specificity is 
determined by the ’’h e l p e r ” ALV referred to as Rous 
associated virus (RAV). An endogenous ALV, RAV-0, was 
supplied by Harriet Robinson ( W F E B ) . It was produced by 
line 100 embryo fibroblasts and grown on ev-1 chicken cells 
susceptible to subgroup E viruses. The titer of the stock 
was approximately 10 million infectious units/ml. All 
viruses were stored in liquid nitrogen except for RAV-0 
which was stored in a REVCO freezer at -70 degrees C.
Titration of Virus
The dose of virus given depended upon the experiment 
but was based upon an average titer for each stock virus.
Two different stocks of RSV-1 were used. The first stock, 
used in characterizing six B genotypes of line UNH 105 for 
response to RSV-1 induced tumors and for testing tumor 
induction susceptibility of (6-1 X 15— 1)F 6 chickens, had a 
titer of approximately 200,000 pock forming units (PFU) per 
ml. This was based upon inoculation of the chorioallantoic 
membrane (CAM) of susceptible 9 to 11 day old SPAFAS chicken 
embryos and counting the number of foci of proliferating 
cells 7 days later (Hitchner e_t aJL. 1975). The diluent for 
this stock, both for titration and for inoculation of
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experimental chickens, was H a n k s ’ balanced salts solution 
containing 5% fetal calf serum plus 100 units penicillin,
100 ug streptomycin and 10 ug hyaluronidase (Sigma Chemical) 
per ml. The second stock of RSV-1 had a titer of 
approximately 1,200,000 PFU per ml. Titers of the RSV-2 and 
RSV-49 stocks were approximately 750,000 and 75,000 PFU per 
ml, respectively. Diluent for the second stock of RSV-1 and 
for the stocks of RSV-2 and RSV-49 was D u l b e c c o ’s Modified 
Eagle Medium (Gibco) with D-glucose, L-glutamine, and sodium 
pyruvate plus 10£ tryptose phosphate broth, 4$ calf serum, 
and 1? antibiotic-antimycotic (Gibco) resulting in 100 units 
penicillin, 100 ug streptomycin, and Q.25 ug Fungizone per 
ml. Change to this diluent was made in efforts to use the 
more accurate focus-forming assay (Hunter 1979) for 
titration of virus. The same medium was used for growth of 
primary and secondary cultures of SPAFAS chick embryo 
fibroblasts (CEF) except for the addition of 1? 
heat-inactivated chicken serum (Gibco).
Titers obtained using the focus assay were generally 
higher than those based on inoculation of C A M ’s. Since CAM 
results were available for all virus stocks used, and 
because a greater number of titrations were performed using 
CAM's, all titers above are reported in PFU's rather than 
F F U 's (focus-forming units).
Normally stock virus was diluted one day prior to use 
for chicken inoculation and stored in a REVCO freezer at -70 
degrees C for 24 hours. It was transported to the UNH
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Poultry Farm in a frozen state, then thawed and kept on ice 
until time of inoculation of chickens. Titered viruses were 
subjected to one freeze/thaw cycle to simulate conditions of 
virus used for inoculation of experimental animals.
Screening the Chicken Lines for ALV
Egg albumins from (6-1 X 15-1)F4 dams were screened for 
presence of ALV using the complement fixation test for avian 
leukosis (Sarma et. aJL. 1964) in the laboratory of Harriet 
Robinson (W F E B ) . Egg albumins from other lines and crosses 
were screened with an enzyme-linked immunosorbent assay 
(Smith et. sJL.« 1 979) by E.O. Mills, Hubbard Farm, Inc., 
Walpole, N.H.
Virus Inoculations
Chickens in a given experiment were inoculated with a 
particular subgroup, or subgroups of RSV at six weeks of 
age. The subgroup(s) of virus and the dilution used 
depended upon the objective of the experiment. One tenth ml 
was injected subcutaneously normally into the left wingweb 
only. Details concerning the virus subgroup(s) used, dose, 
and whether one or both wings were inoculated are given for
m
the individual experiments under Results.
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E v a l u a t i o n  of Tumor D e v e l o p m e n t  and P r o g r e s s i o n
In general, tumors were scored subjectively for size at 
2, 3» 4» 6, 8, and 10 weeks postinoculation (PI). Tumor 
score was based on the following criteria (Collins 
&1. 1977):
Score Criterion
0 No palpable tumor
1 Small tumor <. 0.5 cm diameter
2 Tumor > 0.5 cm and <. 1.2 cm
diameter
3 Tumor > 1.2 cm and ^  1/2
wingweb area
4 Tumor > 1/2 wingweb area
but < total wingweb
5 Tumor fills wingweb
6 Massive tumor extending
beyond the wingweb
A tumor profile index (TPI) was assigned on the basis of the
pattern of tumor growth over the ten week postinoculation
period. In most experiments a five index TPI was used,
based upon the following criteria (Collins .ei. &1.. 1977):
TPI Criterion
1 Complete regression by 28 days
2 Complete regression by 56 days
but after 28 days
3 Complete regression after 56
days, or a decreasing slope,
or complete regression by 56 
days followed by recurrence
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4 General upward trend, or plateau;
slight regression after 56 days
5 Terminal tumor prior to 70 days
To characterize the six B. genotypes of line UNH 105 for 
response to RSV-1 induced tumors (Brown .&£. 1982), a TPI
was assigned to each chicken based upon one of three 
criteria. The criteria were modified to account for the 
different distribution of responses observed with this line, 
there being very few complete regressors by 28 or 56 days 
PI.
TPI Criterion
1 Complete, or nearly complete,
regression (tumor not exceeding 
1.2 cm diameter at 70 days PI)
2 Intermediate response (tumor
exceeding 1.2 cm diameter but 
not completely filling the 
wingweb at 70 days PI)
3 Terminal tumor by 70 days, or
massive tumor completely filling 
or extending beyond the wingweb 
at 70 days PI)
Necropsy
Chickens dying during the experimental period were 
necropsied, and sections of suspect metastatic lesions were 
collected and processed for histological examination under 
the supervision of W.R. Dunlop, poultry pathologist at the 
University of New Hampshire.
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Statistical Analyses
Mean tumor scores and T P I ’s with corresponding standard 
errors were obtained using SPSS subprograms CROSSTABS and 
ONEWAY (Nie e£ &1. 1975). Mean T P I ’s adjusted for the 
effects of other independent variables were obtained using 
the "least-squares and maximum likelihood general purpose 
p r o g r a m ” (Harvey 1968). Analysis of variance and .a 
posteriori contrasts of means were performed using SPSS 
subprograms ANOVA and the modified least significant 
difference (LSDMOD) of subprogram ONEWAY, respectively. 
LSDMOD was used since it is exact for groups of unequal 
sizes. Chi square analyses were performed using SPSS 
subprogram CROSSTABS. Statistical significance was 
determined at P i  0.05.
In computing mean tumor scores by weeks 
postinoculation, any chickens dying of tumor were assigned 
tumor scores of 5 for the remainder of the experimental 
period. If cause of death was suspect, tumor being size 3 
or less at time of death, no tumor scores were assigned for 
subsequent weeks PI. No T P I ’s were assigned to chickens 
receiving RSV inoculations in both wings or to chickens in 
which cause of death was suspect.
IV. R E S U L T S
Evidence for a Non-MHC Influence on Host 
Response to RSV-Induced Tumors
Genetic Influence
RPRL inbred lines 6-1, 6-3. 100, and 7-2 are all 
homozygous for the B2 haplotype, yet differ greatly in 
response to RSV-induced sarcomas. Lines 6-1 and 6-3 are 
regressor lines, whereas lines 100 and 7-2 have been 
associated with a high incidence of tumor progression 
(Collins .et. 19 80) . The objective of the following
studies was to determine whether such variation was due to a 
non-MHC influence (genetic or environmental) or to a 
hitherto undetected difference at the MHC. ALV-negative 
dams, as determined by ELISA testing of egg albumins, were 
u s e d .
To compare the B2 haplotypes of lines 7-2 and 6-1, it 
was necessary to cross these lines with a third line and 
eventually to produce a three way cross which would allow 
comparisons of the two B2 haplotypes on a common genetic 
background. Line 151-5 was chosen for the cross for several 
reasons. Bacon e_t &1. ( 1979) had reported that (151-5 X 
7-2)F1's were highly susceptible to avian leukosis virus. 
Since tumors induced by ALV would share many of the same 
antigens as sarcomas and since both 151-5 and 7-2 had been
reported to be progressor lines (Collins 1 980), it
was suspected that (151-5 X 7-2)F1's would be characterized 
by progressive Rous sarcoma growth. On the other hand, a 
high incidence of regression was expected among (151-5 X
6 - 1 ) F 1 ’s due to the dominant high responding B2 haplotype of 
line 6-1 (Collins .et. ^JL. 1977). Since 151-5 is susceptible 
to subgroup A sarcoma and leukosis viruses, and 
susceptibility is dominant, comparisons between crosses 
could be made using RSV-1 in spite of the subgroup 
resistance of line 7-2.
(151-5 X 6— 1)F 1 and (151-5 X 7-2)F1 chickens were 
produced by inseminating 6-1 and 7-2 dams with pooled semen 
from 151-5 males. Since ALV-negative 151-5 dams were not 
available, the reciprocal matings of 6-1 and 7-2 males with 
151-5 females were not made. Progeny were challenged in the 
left wingweb with approximately 1200 PFU of RSV-1 and in the 
right wingweb with RSV-49 (approximately 75 PFU) at six 
weeks of age. The two sets of F1 generation progeny 
differed greatly in anti-tumor response over the 10 week 
period postinoculation (Figure 1A, page 45). RSV-1 induced 
sarcomas were the same size at two weeks PI for both groups, 
but thereafter (151-5 X 6-1)F1's rapidly regressed their 
tumors, whereas (151-5 X 7 - 2 ) F 1 ’s developed progressive 
tumor growth. Chickens dying as a result of RSV-1 induced 
tumor burden were scored as size 5. throughout the remainder 
of the postinoculation period. If cause of death was 
suspect, no tumor score was assigned to that chicken in
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computation of mean tumor scores in succeeding weeks. Of 31 
(151-5 X 6— 1 )F1*s inoculated with RSV-1, all developed 
tumors, one died of suspect causes, and all the rest (97?) 
rapidly regressed their tumors. Of 32 (151-5 X 7-2)F1's, 
all developed RSV-1 induced tumors, three died of suspect 
causes, and 26 (81?) died with progressive tumor growth. 
Suspect causes of death were those in which tumor size at 
time of death was small (size 3 or less).
Response to the RSV-49 induced tumors is depicted in 
Figure 1B (page 45). Mean tumor scores for (151-5 X 
7-2)F1's are reported only through the fourth week PI due to 
high mortality resulting from massive sarcomas induced by 
RSV-1. Using RSV-49, (151-5 X 6-1)F1»s had 100? tumor 
induction with size 3 or 4 tumors at two weeks PI and 
subsequent rapid tumor regression. In contrast, (151— 5 X 
7 - 2 ) F 1 ’s demonstrated resistance to tumor induction with 
rs.V-49, only 5 of 32 developing tumors. (Chickens which 
did not develop right-wing tumors were not included in 
computation of mean tumor scores depicted in Figure 1B.) 
Tumors which did develop were small, size 1 or 0, at two 
weeks PI. Resistance to tumor induction with RSV-49 had 
been observed with an earlier hatch of the same genetic 
stocks (No comparative regression data was obtained from 
this hatch because of this resistance.). Of eighteen 7-2 
and ten (151-5 X 7-2)F1 chickens inoculated at 6 weeks of 
age with approximately 75 PFU of RSV-49, only four 7-2 and 
no (151-5 X 7-2)F1 chickens developed tumors by two weeks
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PI. (All four tumors were size one.) In contrast, all nine 
(151-5 X 6— 1)F 1 progeny inoculated with the same virus 
developed tumors, only one of which was less than size three 
at two weeks PI. Of twelve 7-2 and eight (151-5 X 7-2)F1 
" no-takes” rechallenged with a 10-fold greater dosage of 
RSV-49, 17 developed tumors.
The above study confirmed an obvious difference between
7-2 and 6-1 in their associated anti-tumor responses, but 
did not localize the source of variation. To better 
evaluate the B2 haplotype of 7-2, ELISA negative 7-2 dams 
were inseminated with (151-5 X 6-3)F1 semen. The resulting 
(151-5 X 6-3)F1 X 7-2 progeny were blood typed to identify 
the segregating B2/B2 and B2/B15 genotypes. They were then 
challenged as above in both left and right wings with 
approximately 1200 PFU RSV-1 and 75 PFU RSV-49, 
respectively. Mean RSV-1 and RSV-49 induced tumor scores 
(Figures 2A and 2B, respectively; page 46) for B2/B2 and 
B2/B15 chickens were compared over the ten-week period PI. 
Both genotypes had a high incidence of regression with both 
subgroups of RSV. Since B 1 5 has been associated with low 
response to RSV-1 (see (151-5 X 6-3)F2 data in Figure 8 A ) , 
the regression associated with the B2/B15 genotype was 
attributed to the B2 haplotype from 7-2 (JB2 in a B2/B15 
genotype could only come from 7-2.). Thus the high 
incidence of progression previously observed in B2/B15 
(151-5 X 7-2)F1's was the result of a non-MHC influence.
In spite of the negative ALV status of the 7-2 dams and
the generally infrequent occurrence of subgroup C ALV 
congenital infections (Tooze 1973)> it is conceivable that 
an undetected low level congenital infection with subgroup C 
ALV could have resulted in both resistance to tumor 
induction with RSV-49 due to virus receptor interference, 
and progressive sarcoma growth due to tolerance. Among the 
35 (151-5 X 6-3)F1 X 7-2 chickens in the above experiment,
15 had size 2 or less RSV-49 induced sarcomas at 2 weeks PI. 
Mean RSV-1 induced tumor scores throughout the 
postinoculation period for these chickens were similar to 
those of (151-5 X 6-3)F 1 X 7-2 chickens with larger RSV-49 
induced tumors the second week PI (Figure 3A, page 47). The 
relative susceptibility to tumor induction with subgroup C 
sarcoma virus appears unrelated to ability to respond to 
tumor induction with subgroup A RSV. The small RSV-49 
induced tumors (at 2 weeks PI) rapidly regressed (Figure 3B, 
page 47), results inconsistent with congenital infection 
with subgroup C ALV.
Concurrently with the (151-5 X 6-3)F1 X 7-2 chickens, 
6-1 X (151-5 X 6-3)F1 and (151-5 X 6-3)F 1 X 6-3 chickens 
were inoculated with the same two viruses at the same time. 
Figures 4A and B (page 48) compare responses of (151-5 X
6-3)F1 X 7-2 chickens with those of the combined 6-1 X 
(151-5 X 6-3)F1 and (151-5 X 6-3)F1 X 6-3 chickens to tumors 
induced by RSV-1 and RSV-49 respectively. Response against 
both RSV-1 and RSV-49 induced sarcomas appears to be more 
rapid in the pooled crosses to 6-1 and 6-3 than in (151-5 X
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6 —3)F 1 X 7-2 chickens. Thus Rous sarcoma regression appears 
to be a quantitative rather than qualitative trait.
Further evidence for a non-MHC influence on Rous 
sarcoma regression was obtained using line 100 and £.2 3/.2.2 3 
line 105 chickens to produce F1 and subsequent F2 and 
backcross progeny. A spectrum of responses associated with 
different B genotypes had been previously observed in line 
105 (Collins ejt &1. ' 1979 » Brown &1. 1982). Therefore the 
background associated with this line did not in general 
appear to be preventing expression of regressor phenotypes. 
If low response associated with the B2 haplotype of line 100 
was the result of genetic background, then changing the 
background could conceivably change the phenotype associated 
with this B haplotype.
(100 X B23/B23 105)F2 and backcross progeny from 
ALV-negative dams (as determined by ELISA testing of egg 
albumins) were blood typed to identify B genotypes B2/B2, 
B 2 / B 2 3 » and B23/B23. Three different subgroups of RSV were 
used for wingweb inoculation at six weeks of age. Virus 
subgroups were assigned to consecutive wing band numbers of 
progeny of the three mating types. Each chicken was 
inoculated in the left wingweb with 1/10 ml of one of the 
following: a 1:100 dilution of RSV-1 (approximately 1200 
PFU), a 1:10 dilution of RSV-2 (approximately 7500 PFU), or 
a 1:100 dilution of RSV-49 (approximately 75 PFU).
Among F2 chickens, the B23/B23 genotype gave the lowest 
anti-tumor response against the RSV-1, RSV-2, and RSV-49
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induced tumors (Figures 9A, B, and C, respectively; page
68). Combining data of S.2 homozygotes and heterozygotes, 
the influence of non-MHC genetic background can be clearly 
seen in Figures 5A, B, and C (page 49). Highest responses 
against all three subgroups of RSV are consistently 
associated with F1 X 105 progeny (I32/B23), whereas lowest 
responses are associated with F1 X 100 progeny (B2/B2 and 
B2/B23). Results of analysis of variance for the B2/B2 and 
B2/B23 genotypes in the F 2 ’s and backcrosses are provided in 
Table 3A (page 50). Responses were evaluated on the basis 
of a 5 index TPI (see Materials and Methods). Mating type 
can be seen to be a significant source of variation (P <. 
0.05). Mean TPI's for the combined B2 homozygotes and 




Increased resistance to tumor induction had become an 
increasingly greater problem among several genetic stocks 
maintained at UNH. Certain dams consistently produced 
progeny susceptible to RSV-1, whereas others produced chicks 
resistant to sarcoma induction. In general, tumors which 
did develop, appeared later in siblings of resistant chicks 
than in chicks from high susceptibility families (Table 4, 
page 52). A C0FAL (Complement Fixation test for Avian 
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T a b l e  3 A .  A n a l y s i s  o f  v a r i a n c e  o f  T P I ' s  f r o m  B 2 / B 2  
a n d  B 2 / B 2 3  c h i c k e n s  p r o d u c e d  b y  ( 1 0 0  x  B 2 3 / B 2 3  1 0 5 ) F 2  
a n d  b o t h  b a c k c r o s s  m a t i n g s .
S o u r c e s  o f  v a r i a t i o n  d . f .  M ean  s q u a r e s
G e n o t y p e 1 0 . 2 2 6
S e x 1 0 . 5 6 0
H a t c h 1 4 . 8 4 5
V i r u s 2 3 . 2 3 0
M a t i n g  t y p e 2 2 4 . 9 6 3 *
R e s i d u a l 1 3 2 1 . 3 7 4
♦ P r o b a b i l i t y  o f  a s s o c i a t e d  F <_ 0 . 0 5 .
D u e  t o  l o w  e g g  p r o d u c t i o n ,  t h e  F I  x  1 0 0  b a c k c r o s s  p r o d u c e d  
n o  p r o g e n y  f o r  t h e  s e c o n d  h a t c h .  B e c a u s e  o f  e m p t y  c e l l s ,  
i n t e r a c t i o n s  w e r e  n o t  c a l c u l a t e d  i n  t h e  a n a l y s i s .
T a b l e  3 B .  Mean T P I ' s  b y  v i r u s  a n d  m a t i n g  t y p e  f o r  
B2 h o m o z y g o u s  a n d  h e t e r o z y g o u s  c h i c k e n s  f r o m  ( 1 0 0  x  
B 2 3 / B 2 3  1 0 5 ) F 2  a n d  b a c k c r o s s  m a t i n g s .
N o . o f
c h i c k e n s  N o .  o f  Mean
M a t i n g  t y p e V i r u s i n o c u l a t e d t u m o r s T P I
( 1 0 0  x  B 2 3 / B 2 3  1 0 5 ) F 0 R S V - 1 3 2 3 2 3 . 9
R S V - 2 2 9 2 0 4 . 0
R S V - 4 9 3 5 3 5 3 . 2
F I  x  1 0 0 R S V - 1 4 4 4 . 8
R S V - 2 5 3 4 . 7
R S V - 4 9 6 6 4 . 7
F I  x  1 0 5 R S V - 1 1 6 1 6 2 . 2
R S V - 2 14 6 2 . 8
R S V - 4 9 1 8 18 2 . 5
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15 — 1)F 5 dams revealed only four negative eggs. All four had 
come from dams producing chicks susceptible to tumor 
induction with RSV-1. The remaining eight eggs were from 
dams that had been producing chicks resistant to tumor 
induction. Since it has been well documented that 
congenital infection with ALV results in resistance to tumor 
induction with sarcoma virus of the same subgroup (Tooze 
1973)» it appeared that congenital infection with a subgroup 
A ALV was the cause of the observed resistance to tumor 
induction with RSV-1 (RSV-1 being subgroup A).
The effect of ALV infection of dams on the response of 
their reciprocal (100 X B23/B23 105)F1 progeny to RSV 
inoculation, tumor size at two weeks PI and ultimately TPI, 
was investigated. Egg albumins from the dams were ELISA 
tested for the presence of ALV. Six-week-old progeny from 
both ALV-positive and ALV-negative dams were inoculated in 
the left wingweb with RSV-1 (approximately 1200 PFU).
Failure to induce a tumor by two weeks PI (tumor score of 
zero) was markedly more frequent in progeny from 
ALV-positive than from ALV-negative dams (Table 5, page 53). 
Chickens which failed to develop tumors by the third week PI 
were terminated. The distribution of progeny to TPI's 
according to the ALV status of their dams showed that the 
incidence of tumor progression (TPI's of 4 and 5) was 
significantly higher in the progeny of ALV-positive dams.
T a b l e  4 .  P e r c e n t  d i s t r i b u t i o n  o f  ( 6 - 1  x  1 5 - 1 ) F 6  c h i c k e n s  t o  
t u m o r  s c o r e  a c c o r d i n g  t o  f a m i l y  s u s c e p t i b i l i t y  t o  R S V -1
S t a t u s  o f  f a m i l y  
f o r  s u s c e p t i b i l i t y
N u m b er  o f  
P r o g e n y
P e r c e n t  d i s t r i b u t i o n  o f  
a c c o r d i n g  t o  t u m o r  s c o r e
c h i c k e n s  
( 9  d a y s P I )  :
t o  R S V -1 0  1 2  3 4 5
S u s c e p t i b l e 2 6 4 9 6 —
R e s i s t a n t 7 6 5 0  1 8  1 2  1 3 4 • 3
C h i c k e n s  w e r e  i n o c u l a t e d  i n  t h e  l e f t  w i n g w e b  a t  2 0  d a y s  o f  a g e  w i t h  R S V -1  ( 1 : 1 0  d i l .  o f  
s t o c k ) .  F o u r  d am s  c o n s i s t e n t l y  p r o d u c i n g  R S V -1  s u s c e p t i b l e  p r o g e n y  p r o d u c e d  t h e  2 6  
c h i c k e n s  i n  t h e  s u s c e p t i b l e  c l a s s .  C h i c k e n s  i n  t h e  r e s i s t a n t  c l a s s  w e r e  f r o m  1 7  d i f f e r e n t  




T a b l e  5 .  D i s t r i b u t i o n  o f  F I  p r o g e n y  f r o m  r e c i p r o c a l  
m a t i n g s  o f  l i n e  1 0 0  b y  B 2 3 / B 2 3  1 0 5  a c c o r d i n g  t o  R S V - 1  
i n d u c e d  t u m o r  s c o r e  ( 2  w e e k s  P I ) ,  T P I ,  a n d  ALV s t a t u s
o f  t h e i r d a m s .
T um or s c o r e  
( 2  w e e k s  P I )
N u m b e r  o f p r o g e n y :
T P I
N u m b e r  o f p r o g e n y :
ALV
p o s i t i v e
d a m s
ALV
n e g a t i v e
d a m s
ALV
p o s i t i v e
d a m s
ALV
n e g a t i v e
d am s
0 2 3 1 1 1 1
1 3 0 2 1 6 4 7
2 2 1 3 1 1 7
3 2 7 2 0 4 1 0 2
4 3 9 4 3 5 2 9 6
9 4 6 5 6 7 6 3
X2 = 2 6 . 5 ;  P < 0 . 0 5 X2  =  2 0 . 1 ;  P < 0 . 0 5
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M a r e k  f s disease
Although both replacements and experimental chickens 
were vaccinated at hatching for Marek's disease (MD) , 
occasionally chickens did succumb to the disease. Since MD 
virus is known to be immunosuppressive (Jakowski .gjt 
a l . 1 970, Calnek e_t a l . 1975), infection could result in 
decreased ability to respond to RSV-induced tumors.
As previously mentioned, some chickens in the 
experiment comparing (151-5 X 6— 1)F 1 and (151-5 X 7-2)F1 
responses to RSV died of suspect causes (page 40), tumors 
being size three or less at time of death. Unfortunately, 
no sections of the bursas were obtained from these to check 
for MD or IBD (infectious bursal disease) involvement. 
However, bursal sections were obtained from four (151-5 X
7-2)F1 chickens dying with large sarcomas. Three of the 
four had lesions characteristic of MD (Calnek and Witter, 
1978).
In the experiment involving (151-5 X 6-3)F1 X 7-2 
chickens (page 41), it was planned that all chickens dying 
during the postinoculation period would have bursal sections 
collected for histological examination. Only six chickens 
died. Bursal sections were obtained from four of them. Of 
these four, two had lesions characteristic of M D .
Figure 6A (page 56) is a photograph of a histological 
section from the bursa of a ten-week-old line 105 chicken 
that had died of progressive Rous sarcoma growth. Aside 
from slight post-mortem changes, the bursa exhibits normal
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architecture. Figure 6B is a photograph of a section from 
the bursa of a (151-5 X 6-3)F1 X 7-2 chicken that had died 
with progressive sarcoma growth. The marked proliferation 
of interfollicular connective tissue and diffuse 
infiltration with lymphocytes is characteristic of MD 
(Calnek and Witter 1978).
A hatch effect was observed in an experiment 
characterizing (151-5 X 6-3)F2 chickens from ALV-negative 
dams for their response to each of three subgroups of RSV. 
(More details of the experiment and results are provided in 
the following section describing the influence of virus 
subgroup on anti-Rous sarcoma response.) There were a total 
of four hatches. Tables 6A and B (page 57) were compiled 
from the combined data of the regressor genotypes, B2/B2 and 
B2/B15. The rank order of hatches for mean TPI is 
approximately the same for all three subgroups of RSV. No
such pattern is observed with mean tumor scores at two weeks 
PI. Thu 3 fluctuations in virus titer from hatch to hatch 
would not explain the lower responses to RSV (higher mean 
T P I ’s) observed in hatch one. Known exposure to MD virus 
occurred with this hatch since four (6-1 X 15— 1)F 2 chickens 
housed with them died of MD shortly before the RSV 
inoculation date. The (151-5 X 7-2)F1,s previously 
described and this hatch of (151-5 X 6 - 3 ) F 2 ’s had the same 
hatch date, were raised in the same building, were 
inoculated with RSV on the same day, and maintained in the
same isolation room during the postinoculation period.
F i g u r e  6A
B u r s a  f r o m  a t e n - w e e k - o l d  l i n e  1 0 5  c h i c k e n  t h a t  h a d  d i e d  
o f  p r o g r e s s i v e  R o u s  s a r c o m a  g r o w t h .  A s i d e  f r o m  s l i g h t  p o s t ­
m o r t e m  c h a n g e s ,  t h e  b u r s a  a p p e a r s  n o r m a l .  H & E;  X 1 0 0 .
B u r s a  f r o m  a t e n - w e e k - o l d  ( 1 5 1 - 5  X 6 - 3 ) FI  X 7 - 2  c h i c k e n  
t h a t  h a d  d i e d  o f  p r o g r e s s i v e  R o u s  s a r c o m a  g r o w t h .  H & E;
X 1 0 0 .
T a b l e  6 A .  Mean T P I ' s  a n d  t u m o r  s c o r e s  ( 2  w e e k s  P I )  b y  
v i r u s  a n d  h a t c h ,  c o m b i n e d  d a t a  o f  B 2 / B 2  a n d  B 2 / B 1 5  
c h i c k e n s  f r o m  a  ( 1 5 1 - 5  x  6 - 3 ) F 2
H a t c h
Mean t u m o r  p r o f i l e  i n d e x :
M ean  t u m o r  s c o r e  
t w o  w e e k s  P I :
a t
R S V - 1 R S V - 2 R S V - 4 9 R S V - 1 R S V - 2 R S V - 4 9
1 2 . 2 3 . 5 2 . 9 3 . 8 2 . 7 3 . 3
2 1 . 7 2 . 6 1 . 8 3 . 5 3 . 0 3 . 3
3 2 . 2 3 . 0 1 . 8 3 . 8 3 . 0 3 . 1
4 1 . 6 2 . 6 1 . 6 3 . 6 2 . 7 3 . 3
T a b l e  6 B .  A n a l y s i s  o f  v a r i a n c e  o f  T P I ' s  f r o m  B 2 / B 2  a n d  
B 2 / B 1 5  ( 1 5 1 - 5  x  6 - 3 ) F 2  c h i c k e n s  c h a l l e n g e d  w i t h  R S V - 1
R S V - 2 ,  o r  R S V - 4 9
S o u r c e s  o f  v a r i a t i o n d . f . M ean  s q u a r e s
G e n o t y p e 1 0 . 5 7 9
S e x 1 0 . 3 2 7
H a t c h 3 3 . 1 0 5 *
V i r u s 2 1 6 . 7 0 8 *
R e s i d u a l 1 8 5 0 . 8 7 0
♦ P r o b a b i l i t y  o f  a s s o c i a t e d  F £  0 . 0 5
S i n c e  n o n e  o f  t h e  t w o  o r  t h r e e - w a y  i n t e r a c t i o n s  w e r e  s i g ­
n i f i c a n t ,  s u c h  w e r e  n o t  i n c l u d e d  i n  t h e  t a b l e .
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Influence of virus subgroup on anti-tumor response
RSV-transformed avian cells have been shown to express 
a variety of antigens relevant to the immune response 
(Ignjatovic et. aJL. 1 978 , Hall _e£. a l . 1979)* Therefore, 
response against tumor cells could involve interactions with 
a wide spectrum of antigenic determinants, each contributing 
in varying degree to the observed anti-tumor response. The 
specificity of B genotype response to RSV-induced tumors was 
investigated with four different F2 populations of chickens. 
Each F2 population was challenged with three different 
subgroups of RSV (RSV-1, RSV-2, and RSV-49 of subgroups A,
B, and C respectively). The F2 populations, the B genotypes 
for which they were segregating, the number of hatches, ALV 
status of dams, and total number of chickens for each F2 
population are provided in Table 7 (page 63). The F2 
populations used were chosen mainly on the basis of 
availability and for the potential of gaining additional 
information such as presence or absence of MHC 
complementation and the effect of B genotype on frequency of 
metastasis. The different populations also provided a type 
of replication of the influence of virus subgroup which 
would tend to allow a broader interpretation of results.
All chickens were blood typed for identification of B 
genotypes and RSV inoculated in the left wingweb at six 
weeks of age. Each chicken received 1/10 ml of one of the 
three sarcoma viruses. Dosages were approximately 1200 PFU, 
7500 PFU, and 75 PFU for RSV-1, RSV-2, and RSV-49
59
respectively. Tumors were scored as usual over the ten-week 
postinoculation period, and T P I ’s were assigned using a 5 
index TPI. Analysis of variance was performed for each F2 
population to determine presence or absence of a significant 
B genotype by virus interaction.
Results from (6-1 X 15-1)F 2 1s . Mean tumor scores for 
(6-1 X 15-1)F2 chickens over the ten-week period 
postinoculation are shown for RSV-1, RSV-2, and RSV-49 
induced tumors in Figures 7A, B, and C, respectively (page 
64). .B5/B.5 chickens were characterized by progressive tumor
growth with each of the three viruses. B2/B2 chickens 
rapidly regressed RSV-1 and RSV-49 induced sarcomas.
Response against RSV-2 was intermediate. Response of B.2/B.5 
heterozygotes for all three virus-induced tumors was similar 
to, but slightly lower than, that of the J32/B2 homozygotes. 
Tumor size at two weeks PI (mean score < 3) indicated that 
the lower response to RSV-2 induced tumors was not due to an 
overwhelming dose of virus. The analysis of variance, Table 
8A (page 65), indicates a significant genotype by virus 
interaction influencing TPI. Least squares mean TPI's by B. 
genotype and virus are given in Table 8B. Highest TPI's 
(lowest responses) for B2/B2 and B2/B5 chickens are 
associated with RSV-2.
Among the (6-1 X 15— 1)F2 chickens, there was a fairly 
high incidence of resistance to both RSV-1 and RSV-49 
induced tumors (38 and 25$, respectively). Resistance to 
RSV-1 was expected in light of the high incidence of ALV
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contamination among the F1 dams (Table 7, page 63) and the 
relatively frequent occurrence of congenital transmission of 
ALV's of subgroup A (Tooze 1973). As expected, only a few 
(8?) of the chickens resistant to RSV-1 came from 
ALV-negative dams. In contrast, 29% of chickens resistant 
to RSV-49 came from ALV-free dams (the approximate 
percentage expected on a purely random b a s i s ) .
To investigate the possibility of undetected ALV 
contamination with a subgroup C virus, sixty J32/B2 (6-1 X 
15-1)F2 chickens from ALV negative dams (as judged by ELISA 
testing of albumins) were challenged at six weeks of age 
with approximately 1200 PFU RSV-1 in the left wingweb and 75 
PFU RSV-49 in the right. All chickens developed size 3 or 4 
RSV-1 induced tumors by two weeks PI. Fourteen of the sixty 
chickens (23?) appeared to be resistant to tumor induction 
with RSV-49, tumors being small (size 1) or absent at two 
weeks PI. Mean RSV-1 induced tumor scores for the second, 
third, and fourth weeks PI for these fourteen chickens were 
similar to those of the other 46 with larger (size 3) RSV-49 
induced tumors the second week PI (Figure 10A, page 71).
The small RSV-49 induced tumors rapidly regressed (Figure 
10B). Thus variation in susceptibility to tumor induction 
with RSV-49 did not appear to be the result of congenital 
contamination with a subgroup C ALV.
Results from ( 151-5 X 6-3)F 2 1s . Combined data of four 
hatches of (151-5 X 6-3)F2 chickens from ALV-free dams gave 
the mean tumor scores in Figures 8A, B, and C (page 66).
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B2/B2 and B2/B15 ohickens had nearly identical responses to 
all three viruses. They rapidly regressed both RSV-1 and 
RSV-49 induced sarcomas. They also regressed RSV-2 induced 
sarcomas, but at a slower rate. B15/B15 responses against 
RSV-1 and RSV-2 induced sarcomas were relatively low, 
whereas the corresponding response to RSV-49 induced tumors 
was characterized by fairly rapid tumor regression from the 
second to the fourth week PI with a subsequent plateau in 
response. The results of the analysis of variance are given 
in Table 9A (page 67)• Again there is a significant 
genotype by virus interaction. The adjusted least squares 
mean TPI's for each B genotype against each of the three 
virus induced tumors (Table 9B) demonstrate the interaction 
e f f e c t .
Results from (100 X B23/B23 1 05)F2 1 s . Mean tumor 
scores for (100 X B23/B23 105)F2 chickens (from ALV-negative 
dams) over the ten-week postinoculation period are depicted 
for RSV-1, RSV-2, and RSV-49 induced sarcomas in Figures 9A, 
B, and C, respectively (page 68). B2 homozygotes and 
heterozygotes had lower responses to all three virus induced 
tumors than associated with the (6-1 X 15-1)F2 and (151-5 X 
6-3)F2 populations described above. This depressed response 
was attributed to a non-MHC influence associated with line 
100 (see Figures 5A, B, and C; page 49). B23/B23 response
was low against all three virus induced tumors. The results 
of the analysis of variance are given in Table 10A (page
69). No significant genotype by virus interaction is
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indicated. The distribution to TPI for (100 X 105)F2 .B2/B2 
homozygotes (Table 10B), however, appears to be similar to 
that found in the other F2 populations, lowest response 
being associated with RSV-2 induced sarcomas.
Results from r B5/B5 (6-1 X 15-1 ) F5 £  B24/B24 1 0 5 ] F 2 ,s.. 
B5/B5 (6-1 X 15-1)F 5 chickens were crossed with B24/J524 line 
105's. The resulting "F1" population was then used in a 
flock mating to produce two hatches of F2 progeny. Table 11 
(page 70) provides the distribution to TPI, by genotype, for 
each tumor virus. All three B genotypes were characterized 
by progressive tumor growth for each of the challenge 
viruses. The lack of resistance to tumor induction with 
RSV-1 in these chickens was not expected in light of 
probable contamination of the parental (6-1 X 15— 1)F 5 stock 
with subgroup A ALV (see page 44).
Stress
An attempt to evaluate the significance of stress as a 
source of variation in anti-tumor response was made using 
dexamethasone and (151-5 X 6-3)F2 B2/B2 and B1 5 / B 1 5 
chickens. Choice of chickens was based on their ALV-free 
status and availability. Dexamethasone is a synthetic 
corticosteroid with approximately 25 times the 
anti-inflammatory potency of hydrocortisone (Haynes and 
Larner 1975). Under the assumption that at least some of 
the immunosuppressive effects of stress result from 
increased blood levels of corticosteroids (Monjan and
T a b l e  7 .  S e g r e g a t i n g  B g e n o t y p e s ,  ALV s t a t u s  o f  d a m s ,  n u m b e r  o f  h a t c h e s ,  a n d  
n u m b e r  o f  c h i c k e n s  i n o c u l a t e d  w i t h  p e r c e n t  t u m o r  i n d u c t i o n ,  b y  v i r u s ,  f o r  e a c h
F2  p o p u l a t i o n  u s e d  f o r e v a l u a t i n g  t h e s p e c i f i c i t y  o f a n t i - R o u s s a r c o m a  r e s p o n s e .
N um b er o f  c h i c k e n s
S e g r e g a t i n g ALV s t a t u s N o . o f i n o c u l a t e d  a n d  p e r c e n t
F2  p o p u l a t i o n B g e n o t y p e s o f  dams h a t c h e s t u m o r i n d u c t i o n ,  b y v i r u s :
R S V - 1 R S V -2 R S V - 4 9
( 6 - 1  x  1 5 - 1 ) F 2 2 / 2 , 2 / 5 , 5 / 5 p o s i t i v e 1 1 0 0 9 7 9 7
( a p p r o x .  70%) (6 2 % ) ( 1 0 0 % ) (7 5 % )
( 1 5 1 - 5  x  6 - 3 ) F 2 2 / 2 , 2 / 1 5 , 1 5 / 1 5 n e g a t i v e 4 1 0 9 1 0 7 1 0 6
( 1 0 0 % ) (97% ) (7 7 % )
( 1 0 0  x  1 0 5 ) F 2 2 / 2 , 2 / 2 3 , 2 3 / 2 3 n e g a t i v e 2 4 0 3 7 3 9
* ( 1 0 0 % ) (7 6 % ) ( 1 0 0 % )
{ ( 6 - 1  x  1 5 - 1 ) F 5  x  1 0 5 } F2 5 / 5 , 5 / 2 4 , 2 4 / 2 4 p o s i t i v e 2 7 0 ' 6 4 7 9
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F i g u r e s  7 A,  B ,  a n d  C.
Mean t u m o r  s c o r e s  by 
w e e k s  p o s t i n o c u 1 a t i o n  f o r  
( 6 - 1  X 1 5 —1 ) F2 c h i c k e n s  
c h a l l e n g e d  i n  t h e  l e f t  w i n g w e b  
wi  t h  RSV- 1  ( F i g .  7A)  , RSV- 2  
( F i g .  7 B ) , o r  RS V- 4 9  ( F i g .  7C)  . 
B 2 / B 2  , B 2 / B 5  , a n d  B5 / B5 
c h i c k e n s  a r e  r e p r e s e n t e d  by 
s o l i d ,  d a s h e d ,  a n d  d o t t e d  
l i n e s ,  r e s p e c t i v e l y .  S t a n d a r d  
e r r o r s  a r e  i n d i c a t e d  by 
v e r t i c a l  l i n e s .
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Table 8A. Analysis of variance of TPI's of (6-1 x 15-1)F2
chickens challenged with RSV-1, RSV-2, or RSV-49
S o u r c e s  o f  v a r i a t i o n  d . f . M ean  s q u a r e s
M a i n  e f f e c t s
G e n o t y p e  ( G )  2 1 7 . 2 6 8 *
S e x  ( S )  1 0 . 5 3 3
V i r u s  ( V )  ..“ 2 7 4 . 2 3 5 *
I n t e r a c t i o n s
G x  S 2 0 . 1 9 7
G x  V 4 5 . 0 3 1 *
S x  V 2 0 . 7 4 3
G x  S x  V 4 0 . 4 7 9
R e s i d u a l  2 1 4 0 . 8 3 8
♦ P r o b a b i l i t y  o f  a s s o c i a t e d  F £  0 . 0 5 .
T a b l e  8 B .  
v i r u s  f o r
L e a s t  
( 6 - 1  x
s q u a r e s
1 5 - 1 ) F 2
m e a n  T P I ' s  b y  
c h i c k e n s .
B g e n o t y p e  a n d
Mean T P I , b y  v i r u s :
B g e n o t y p e R S V - 1 R S V - 2  R S V - 4 9
B 2 / B 2 2 . 1 3 . 7  2 . 4
B 2 / B 5 2 . 7 4 . 1  3 . 5
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F i g u r e s  8 A,  B ,  a n d  C.
Mean t u m o r  s c o r e s  by  
w e e k s  p o s t i n o c u l a t i o n  f o r  
( 1 5 1 - 5  X 6 - 3 ) F2 c h i c k e n s  
c h a l l e n g e d  i n  t h e  l e f t  w i n g -  
we b  w i t h  RSV- 1  ( F i g .  8 A ) , 
RSV- 2  ( Fi  g .  8 B ) , o r  RS V- 4 9  
( Fi g . 8C)  .
B 2 / B 2 ,  B 2 / B 1 5 ,  a n d  B 1 5 / B 1 5  
c h i c k e n s  a r e  r e p r e s e n t e d  by  
s o l i d ,  d a s h e d ,  a n d  d o t t e d  
l i n e s ,  r e s p e c t i v e l y .  S t a n d a r d  
e r r o r s  a r e  i n d i c a t e d  by 
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Table 9A. Analysis of variance of TPI's from
(151-5 x 6-3)F2 chickens challenged with RSV-1,
RSV-2, or RSV-49
S o u r c e s  o f  v a r i a t i o n d . f . M ean  s q u a r e s
M a i n  e f f e c t s  
G e n o t y p e  ( G )  
S e x  ( S )
V i r u s  ( V )  





4 3 . 8 1 5 *
0 . 1 5 9
1 2 . 3 3 3 *
5 . 3 7 2 *
T w o - w a y  i n t e r a c t i o n s  
G x  V 
G x  S 




4 . 7 3 2 *
0 . 0 9 3
4 . 5 5 3 *
R e s i d u a l 2 7 8 0 . 9 2 8
♦ P r o b a b i l i t y  o f  a s s o c i a t e d  F £  0 . 0 5 .
T a b l e  9 B .  L e a s t  s q u a r e s  m e a n  T P I ’ s  b y  
v i r u s  f o r  ( 1 5 1 - 5  x  6 - 3 ) F 2  c h i c k e n s .
B g e n o t y p e  a n d
Mean T P I , b y  v i r u s :
B g e n o t y p e R S V - 1 R S V - 2  R S V - 4 9
B 2 / B 2 2 . 1 2 . 9  2 . 1
B 2 / B 1 5 1 . 9 3 . 0  1 . 9
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Table 10A. Analysis of variance of TPI's of
(100 x B23/B23 105)F2 chickens challenged
with RSV-1, RSV-2, or RSV-49.
S o u r c e s  o f  v a r i a t i o n  d . f .  M ean  s q u a r e s
G e n o t y p e 2 9 . 5 9 7 *
S e x 1 0 . 0 6 1
V i r u s 2 1 . 7 4 3
H a t c h 1 0 . 6 8 6
R e s i d u a l 8 7 1 . 4 4 0
♦ P r o b a b i l i t y  o f  a s s o c i a t e d  F <_ 0 . 0 5 .
I n t e r a c t i o n s  w e r e  n o t  f o u n d  t o  b e  s i g n i f i c a n t ,  a n d  t h u s  w e r e  
n o t  i n c l u d e d  i n  t h e  t a b l e .
T a b l e  1 0 B .  D i s t r i b u t i o n  o f  B 2 / B 2  ( 1 0 0  x  B 2 3 / B 2 3  1 0 5 ) F 2  
c h i c k e n s  t o  T P I ,  b y  v i r u s .
D i s t r i b u t i o n  o f  c h i c k e n s  t o
T P I  a c c o r d i n g  t o  v i r u s :______
V i r u s  1 2  3  4  5
R S V - 1  —  2  2  —  4
R S V - 2  1 3  3
R S V - 4 9  —  4  2  —  2
T a b l e  1 1 .  D i s t r i b u t i o n  t o  T P I  b y  g e n o t y p e  a n d  v i r u s  f o r  
{ ( 6 - 1  x  1 5 - 1 ) F 5  x  E 2 4 / S 2 4  1 0 5 }  F 2  c h i c k e n s  c h a l l e n g e d  
w i t h  R S V - 1 ,  R S V - 2 ,  o r  R S V - 4 9
D i s t r i b u t i o n  o f  c h i c k e n s  t o  
T P I  a c c o r d i n g  t o  B g e n o t y p e
a n d  c h a l l e n g e  v i r u s : ___________
B g e n o t y p e  V i r u s  1 2  3 4  5
B 5 / B 5  R S V - 1  —  —  —  —  1 7
R S V - 2  —  —  2  8
R S V - 4 9  —  —  —  1 1 1
B 5 / B 2 4  R S V - 1  —  —  —  —  3 7
R S V - 2  —  —  —  5  1 5
R S V - 4 9  —  —  —  1 1 8
B 2 4 / B 2 4  R S V - 1  —  —  1 —  1 4
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F i g u r e  10B
F i g u r e s  10A a n d  B.
Mean l e f t  ( F i g .  10A)  a n d  r i g h t  ( F i g .  10B)  w i n g  t u m o r  s c o r e s  by w e e k s  p o s t ­
i n o c u l a t i o n  f o r  B2/B^2 ( 6 - 1  X 1 5 - 1 )  F2 c h i c k e n s  c h a l l e n g e d  i n  t h e  l e f t  w i n g w e b  
w i t h  RSV- 1  a n d  i n  t h e  r i g h t  w i t h  R S V - 4 9 .  D a s h e d  l i n e s  r e p r e s e n t  c h i c k e n s  w i t h  
s m a l l  ( s i z e  2 o r  l e s s )  RS V- 4 9  i n d u c e d  t u m o r s  a t  2 w e e k s  P I .  C h i c k e n s  w i t h  l a r g e r  
RS V- 4 9  i n d u c e d  t u m o r s  ( g r e a t e r  t h a n  s i z e  2 )  a t  2 w e e k s  PI  a r e  r e p r e s e n t e d  by t h e  
s o l i d  l i n e s .  S t a n d a r d  e r r o r s  a r e  i n d i c a t e d  by  t h e  v e r t i c a l  l i n e s .
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Collector 1977, Eskola ei gl. 1978), B2/B2 and 115/B15 
chickens were given intramuscular (IM) injections of 
dexamethasone prior to and following left wingweb challenge 
with approximately 1200 PFU of RSV-1. Injections of 
dexamethasone (0.6 mg/chicken) were given the day of RSV 
challenge and on 3, 6, 10, 14, and 21 days PI. A 2 mg dose
of dexamethasone was given on the 24th day PI. For 
perspective, the daily anti-inflammatory dosage for a horse 
is 2.5 to 5 mg IM (McDonald 1969). There were ten B2/J32 and 
fourteen B15/B15 dexamethasone treated chickens as well as 
seven B2/B2 and eleven B15/B15 controls (no dexamethasone 
injections). Mean tumor scores and T P I ’s were obtained for 
both treatment and controls. Mean tumor scores by weeks 
postinoculation are provided in Figures 11A and B (page 73). 
Treatment and control groups do not appear to differ 
significantly. If stress was applied, it was not 
sufficiently immunosuppressive to influence anti-tumor 
response.
Interaction of MHC Haplotvpes in Relation to 
Rous Sarcoma Regression
Six B genotypes (three B haplotypes) of noninbred line 
UNH 105 were characterized for ability to respond to RSV-1 
induced sarcomas. The genotypes were as follows: J323/B23, 
B24/B24, B26/B26, B23/B24, B 2 3 / B 2 6 , and B24/B26. A variety 
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F i g u r e  1 1 B
F i g u r e s  1 1 A a n d  B.
Mean t u m o r  s c o r e s  by w e e k s  p o s  t  i n o c u l  a t  i on f o r  B2/ ] 32 ( F i g .  1 1 A) a n d  B1 5 / I 3 1 5  
( F i g .  1 I B ) ( 1 5 1 - 5  X 6 - 3 ) F2 c h i c k e n s  c h a l l e n g e d  i n  t h e  l e f t  w i n g w e b  w i t h  R S V - 1 .  
C o n t r o l  a n d  d e x a m e t h a s o n e  t r e a t e d  c h i c k e n s  a r e  r e p r e s e n t e d  by  d a s h e d  a n d  s o l i d  
l i n e s ,  r e s p e c t i v e l y .  S t a n d a r d  e r r o r s  a r e  i n d i c a t e d  by  v e r t i c a l  l i n e s .
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B genotype. Six-week-old chickens were inoculated in the 
left wingweb with approximately 20 PFU of RSV-1. This 
dosage of RSV-1 was less than that used in the previously 
described studies. (Using higher doses in this line results 
in a very low incidence of tumor r e g r e s s i o n ) . Tumors were 
scored as usual over the ten-week postinoculation period, 
and TPI's were assigned on the basis of a three index TPI 
(see Materials and Methods). The three index TPI, a 
modification of the five index TPI of Collins slL  a l .
(1977), was used due to the infrequency of complete 
regression observed among chickens of line UNH 105. The 
percentage distribution of chickens to T P I ’s according to £  
genotype is given in Table 12A (page 77). In an analysis of 
variance with TPI as the dependent variable and £  genotype , 
sex, and hatch as independent variables (Table 12B), £  
genotype was a significant source of variation. Results of 
a means separation test (modified least significant 
difference of SPSS subprogram ONEWAY) are given in Table 12C 
(page 78). The homozygous genotypes £23/B23, B26/£26, and 
£24/£24 had mean T P I ’s of 2.0, 2.3, and 2.9 respectively, 
which differed significantly in all comparisons, £23/B23 
having the highest response and £24/£24 the lowest. When 
the £24 haplotype combined with either the £23 or £26 
haplotype, anti-tumor response appeared to be slightly lower 
than that observed for homozygotes of the respective better 
responding £  haplotype, £23 or £26, suggesting a gene dose 
effect. Highest anti-tumor response was observed among
1i
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B23/B26 heterozygotes, suggesting complementation of the B23 
and B26 haplotypes for response to RSV-1 induced sarcomas. 
Only one third of the B23/B26 heterozygotes were produced 
from B23/B26 X B23/B26 type matings. B23/123 and B23/B26 
siblings from such matings, although demonstrating the same 
trend as with the combined data of all mating types, did not 
differ significantly in their anti-tumor response. Thus the 
possible influence of a non-MHC genetic or environmental 
factor cannot be ruled out.
Results suggestive of complementation (allelic and/or 
non-allelic) were also obtained using line 100 and I123/B23 
line 105 chickens and progeny of the reciprocal F1 crosses 
(Table 13» page 79). There were a total of four hatches.
At six weeks of age, chickens were inoculated in the left 
wingweb with approximately 1200 PFU of RSV-1. Tumors were 
scored as usual and a five index TPI (see Materials and 
Methods) was used to evaluate anti-tumor response. (100 X 
105)F1 chickens (B2/B23) had higher anti-tumor responses 
(lower T P I ’s) than those observed with either parental type. 
Such results could be explained by both MHC and non-MHC 
genetic effects. The chickens used were not from ALV-free 
dams, a fairly high incidence of ALV contamination being 
found among line 100 dams and a low incidence among line 105 
dams. Therefore, the high anti-tumor response associated 
with progeny from the 100 X 105 mating type could have 
resulted from the favorable combination of the B2 haplotype 
from line 100 and ALV-free line 105 dams. As previously
i76
noted (page 51), a comparison of F1 progeny from 
ALV-negative and -positive dams clearly indicated that the 
ALV status of the dams did significantly influence the 
anti-tumor response of the progeny (see Table 5, page 53).
A (100 X B23/B23 105)F2 population (see page 43) 
produced from ALV-negative dams provided no evidence of MHC 
complementation. B2/B23 responses to RSV-1, RSV-2, and 
RSV-49 induced sarcomas were slightly lower than those 
associated with B2/B2 (Figures 9A, B, and C; page 68). On
the other hand, evidence of complementation presumably 
resulting from the favorable combination of the B2 haplotype 
of line 100 with the non-MHC background of line 105 was 
obtained in the comparisons of F2 and backcross progenies of 
lines 100 and 105 (Figures 5A, B, and C; page 49). Highest 
anti-tumor responses were associated with B2/J323 progeny 
from the backcross to line 105. All dams were ALV-negative.
Attempts to Localize the Non-MHC Genetic Influence 
on Rous Sarcoma Regression
Endogenous Virus, RAV-0
Line 7-2 is homozygous for e v - 2 . a locus which codes 
for the nondefective endogenous ALV, RAV-0 (Astrin ,§_t 
a l . 1 980). Lines 6-1 and 6-3 lack this endogenous virus, 
but they do have e v - 1 . a locus coding for a defective 
endogenous virus that produces virus envelope (Astrin £_t 
a l . 1 979; Robinson, personal communication). Although
77
Table 12A. Percentage distribution of line UNH 105
chickens to TPI’s, by B genotype, for tumors induced
by RSV-1.
P e r c e n t a g e  d i s t r i b u t i o n  t o
t u m o r  p r o f i l e  i n d e x :
B g e n o t y p e 1 2  3
2 3 / 2 6 5 4 2 3 2 3
2 3 / 2 3 3 4 3 2 3 4
2 3 / 2 4 1 7 3 9 4 4
2 6 / 2 6 2 6 1 5 5 9
2 4 / 2 6 1 4 2 1 6 5
2 4 / 2 4 . 0 1 3 8 7
T a b l e  1 2 B .  A n a l y s i s  o f  
c h i c k e n s  c h a l l e n g e d  w i t h
v a r i a n c e  o f  T P I ’ s  
R S V - 1 .
o f  l i n e  1 0 5
S o u r c e s  o f  v a r i a t i o n d . f . Mean s q u a r e s
G e n o t y p e 5 1 5 . 0 8 3 *
S e x 1 0 . 0 0 0
H a t c h 5 1 . 3 7 4 *
R e s i d u a l 7 3 3 0 . 6 1 2
♦ P r o b a b i l i t y  o f  a s s o c i a t e d  F <_ 0 . 0 5 .
I n t e r a c t i o n s  w e r e  n o t  f o u n d  t o  b e  s i g n i f i c a n t ,  a n d  t h u s  w e r e  
n o t  i n c l u d e d  i n  t h e  t a b l e .  I n  a  s e c o n d  a n a l y s i s  i n  w h i c h  
i n t e r a c t i o n  e f f e c t s  w e r e  p o o l e d  w i t h  t h e  r e s i d u a l ,  h a t c h  
e f f e c t  w a s  n o t  s i g n i f i c a n t  ( s e e  B r o w n  e t  a l . ,  1 9 8 2 ) .
T a b l e  1 2 C .  Mean T P I ’ s  b y  B g e n o t y p e  t o g e t h e r  w i t h  a  m e a n s  s e p a r a t i o n  t e s t  f o r  
l i n e  UNH 1 0 5  c h i c k e n s  c h a l l e n g e d  w i t h  R S V - 1 .
B g e n o t y p e :
2 3 / 2 6 2 3 / 2 3 2 3 / 2 4  2 6 / 2 6 2 4 / 2 6 2 4 / 2 4
Mean TPI 1 . 7 a * 2 .  0 b 2 .  3 b c 2 .  3 C 2 .  5 C 2 . 9 d
N u m b e r / g e n o t y p e 1 4 5 1 7 6 8 8 1 8 1 1 3 3 7 6
♦ M e a n s  h a v i n g  n o  s u p e r s c r i p t s  i n  common a r e  s i g n i f i c a n t l y  d i f f e r e n t ,  P _< 0 . 0 5 .
T a b l e  1 3 .  Mean t u m o r  s c o r e s  a t  t w o  w e e k s  P I  a n d  m e a n  T P I ' s  a c c o r d i n g  t o  m a t i n g  t y p e  
f o r  l i n e  1 0 0 ,  B 2 3 / B 2 3  l i n e  1 0 5  a n d  ( 1 0 0  x  1 0 5 )  r e c i p r o c a l  F I  c h i c k e n s  c h a l l e n g e d  i n  
t h e  l e f t  w i n g w e b  w i t h  R S V - 1 .
M a t i n g  t y p e  
( M a l e )  ( F e m a l e )
B g e n o t y p e  
o f  p r o g e n y
Mean t u m o r  
s c o r e ++
N um ber  o f  
c h i c k e n s
Mean
TPI
N um ber  o f  
c h i c k e n s
1 0 0  x  1 0 0 2 / 2 3 . 2 5 b+ 5 5 3 . 4 9 b + 5 5
1 0 0  x  1 0 5 2 / 2 3 3 . 6 4 a 3 7
oo00•<N 4 0
1 0 5  x  1 0 0 2 / 2 3 3 . 4 7 ab 9 6 3 . 3 2 b c 9 6
1 0 5  x  1 0 5 2 3 / 2 3 3 . 8 0 a 1 2 5 4 . 3 7 a 1 2 6
♦ M e a n s  h a v i n g  n o  s u p e r s c r i p t s  i n  common d i f f e r  s i g n i f i c a n t l y , P  <_ 0 . 0 5 .
♦♦M ean  t u m o r  s c o r e s  a t  t w o  w e e k s  P I  ( b i r d s  w i t h o u t  t u m o r s  e x c l u d e d ,  i n c l u d i n g  4  b i r d s  
w h i c h  d e v e l o p e d  t u m o r s  b y  t h e  t h i r d  w e e k  a n d  w e r e  a s s i g n e d  T P I ' s .
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presence of the defective endogenous virus encoded by ev-3 
does not result in progressive sarcoma growth in lines 6-1 
and 6-3» it is conceivable that RAV-0, a nondefective 
endogenous virus capable of replication, may influence 
response (perhaps by tolerizing the host to a non-virion 
antigen associated with ALV replication). The possible 
influence of the ev-2 locus was evaluated using lines 6-1 
and 7-2. Line 6-1 dams were inseminated with the pooled 
semen from 6-1 and 7-2 males. Thus both 6-1 and (7-2 X 
6 — 1>F 1 chickens were produced simultaneously by the same 
dams thereby reducing the influence of maternal effects on 
results. Progeny were blood typed for E genotype to 
differentiate 6-1 chickens from (7-2 X 6-1)F1's.
Six-week-old chickens were inoculated in the left wingweb 
with approximately 1200 PFU of RSV-1. The distribution of 
TPI's to 6-1 and (7-2 X 6 — 1)F 1 chickens is provided in Table 
14 (page 83). Sample size is too small to differentiate 
between the two groups. Of significance, however, is the 
observation that only 2 of 12 (7-2 X 6— 1)F 1 progeny 
demonstrated progressive tumor growth (TPI of 4 or 5) which 
differs considerably from the high incidence of progression 
observed among (151-5 X 7-2)F1 chickens (page 39). Since 
both (7-2 X 6— 1)F 1 and (151-5 X 7-2)F1 chickens are 
heterozygous for presence of e v - 2 . yet another variable must 
have been responsible for the high incidence of progression 
among ( 151-5 X 7-2)F1's.
Line K28 is a noninbred line with only one endogenous
r8 1
virus, encoded by e v - 1 (Robinson £t. 1 980). This
endogenous virus, present in nearly all White Leghorn lines
tested so far, produces neither intact virus nor envelope
antigens (Astrin and Robinson 1979). The cells of this line
of chickens, free of interference from subgroup E virus
envelope antigens, have the capacity for efficient
replication of subgroup E viruses such as RAV-0. For this
reason, line K28 chickens were used in an attempt to
immunize against Rous sarcoma challenge using the endogenous
virus, RAV-0. Chickens were divided into four treatment
groups each of which received three biweekly inoculations
prior to challenge with RSV-1 (approximately 1200 PFU) in
the left wingweb and RSV-2 (approximately 7500 PFU) in the
right wingweb at eight weeks of age. The biweekly
inoculations (given at 16, 28, and 42 days after hatching)
for the four treatment groups were as follows:
Group 1 - RAV-0 stock, 1 ml IM
Group 2 - Dulbeccos MEM, 1 ml IM (Control)
Group 3 - RAV-1, 1:100 dil. of stock (1 ml IM)
*
Group 4 - 6-1 embryo tissue (11 day), a source 
of subgroup E virus envelope 
(5% suspension, 1 ml subcut.).
If RAV-0 replicating cells or chf(+) cells bear surface
antigens similar to those involved in anti-Rous sarcoma
response, then immunization with RAV-0 (Treatment group 1) 
or with chf(+) cells (Treatment group 4) should result in 
enhanced response to RSV-induced tumors. Immunization with
8 2
the exogenous ALV, RAV-1, has been previously shown to 
result in enhanced anti-Rous sarcoma response (Meyers 
al. 1972).
Mean tumor scores for each treatment group over the ten 
weeks following inoculation with RSV are shown for RSV-1 and 
RSV-2 induced sarcomas in Figures 12A and B, respectively 
(page 84). Tumors which did not develop were not included 
in the computation of mean tumor scores. The distribution 
of two week tumor scores to treatment group are provided for 
RSV-1 and RSV-2 induced tumors in Table 15 (page 85). 
Considerable variablity is apparent within each treatment 
group. There is no evidence of enhanced anti-tumor response 
in chickens immunized with either RAV-0 or with 6-1 embryo 
tissue. Chickens immunized with RAV-1, on the other hand, 
demonstrated greater resistance to tumor induction with both 
subgroup A and subgroup B RSV, indicating that such 
resistance was not the result of virus receptor interference 
(Interference by RAV-1 would be limited to subgroup A 
v i r u s e s .).
The E, Blood-Group Locus
Progressor lines 7-2, 100, and 151-5 are homozygous for 
the E5 haplotype, whereas regressor lines 6-1 and 6-3 are 
homozygous for E 7 • The (151-5 X 6-3)F1 X 7-2 chickens used 
for evaluating the B2 haplotype of line 7-2 (page 41) 
provided an opportunity for determining whether or not 
response to Rous sarcoma was associated with the E.
T a b l e  1 4 .  D i s t r i b u t i o n  o f  T P I ' s  t o  6 - 1  a n d  ( 7 - 2  x  6 - 1 )  F I  c h i c k e n s  f o l l o w i n g  c h a l ­
l e n g e  w i t h  R S V -1
M a t i n g T y p e D i s t r i b u t i o n
----1 .
o f  c h i c k e n s t o  T P I a c c o r d i n g t o  m a t i n g  t y p e
( M a l e ) ( F e m a l e ) 1 2 3 4 5
7 2 x  6^ 1 4 5 1 1
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Mean t u m o r  s c o r e s  b y  w e e k s  p o s t i n o c u l a t  i o n  f o r '  K28  c h i c k e n s  c h a l l e n g e d  i n  t h e  
l e f t  w i n g w e b  w i t h  RSV- 1  ( F i g .  12A)  a n d  i n  t h e  r i g h t  ( F i g .  12B)  w i t h  R S V - 2 .  The  
l e g e n d  f o r  t h e  t h r e e  t r e a t m e n t  g r o u p s  p l u s  c o n t r o l s  i s  a s  f o l l o w s :
G r o u p  1 - RAV- 0 i m m u n i z e d  
G r o u p  2 - c o n t r o l s  
G r o u p  3 - RAV-1 i m m u n i z e d
G r o u p  4 - i m m u n i z e d  w i t h  l i n e  6 - 1  e m b r y o  t i s s u e .
T a b l e  1 5 .  D i s t r i b u t i o n  o f  t u m o r  s c o r e s  ( 2  w e e k s  P I ) ,  
a c c o r d i n g  t o  t r e a t m e n t  a n d  v i r u s ,  f r o m  K 28  c h i c k e n s
c h a l l e n g e d  i n  t h e  
w i t h  R S V - 2 .
l e f t  w i n g  w i t h  R S V - 1 a n d i n  t h e r i g h t
T r e a t m e n t
D i s t r i b u t i o n  o f  t u m o r  
( 2  w e e k s  P I )  a c c o r d i n g  
t r e a t m e n t :
s c o r e s
t o
g r o u p 0 1 2 3 4
R A V -0  i m m u n i z e d
R S V - 1
9 1 1
C o n t r o l s 1 2 7
R A V -1  i m m u n i z e d 6 1 2 4 1
I m m u n i z e d  w i t h  l i n e  
6 - 1  e m b r y o  t i s s u e 3 1 1
R A V -0  i m m u n i z e d 1 3
R S V - 2
7 9
C o n t r o l s 1 4 3 1 1 —
RAV-1  i m m u n i z e d 9 2 — 3 —
I m m u n i z e d  w i t h  l i n e  
6 - 1  e m b r y o  t i s s u e — 2 3 9 —
8 6
blood-group locus (The segregating S.2/B2 and B2/I315 
genotypes in that experiment did not differ.). The decision 
to evaluate a possible E. locus effect was made in retrospect 
while the experiment (page 41) was in progress. Four 
chickens had died. The remaining 31 chickens were blood 
typed for E all o a n t i g e n s . There were 18 E.5/JjL5 homozygotes 
and 13 E5/E7 heterozygotes. Their responses to RSV-1 and 
RSV-49 induced sarcomas are diagramatically represented in 
Figures 13A and B, respectively (page 87)* There is no 
indication of depressed anti-sarcoma response among the 
E5/E5 homozygotes. These results confirm previous 
observations with (6-3 X 100)F2 chickens segregating at the 
E locus (Collins, unpublished data).
MHC vs Non-MHC Influences on Metastasis
In the study characterizing six B. genotypes of line 105 
for response to RSV-1 induced tumors (page 72), the overall 
incidence of histologically confirmed metastasis among line 
105 chickens with terminal tumors was approximately 27%. £
genotype did not appear to significantly influence the 
frequency of metastasis (Table 16, page 90). This 
incidence, however, was substantially lower than that for 
gross metastasis previously observed among B5/B5 (6-1 X 
15— 1 )F 2 chickens (Collins .§£ jJ.. 1977). Neither length of 
time from inoculation to death (Table 17A, page 91) nor sex 
(Table 17B) appeared to significantly influence the
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F i g u r e  13B
Fi g u r e s  13A a n d  B .
Mean t u m o r  s c o r e s  by w e e k s  p o s t i n o c u l a t i o n  f o r  ( 1 5 1 - 5  X 6 - 3 ) FI  X 7 - 2  c h i c k e n s  
c h a l l e n g e d  i n  t h e  l e f t  w i n g w e b  w i t h  RSV- 1 ( F i g .  12A)  a n d  i n  t h e  r i g h t  w i t h  
RS V- 4 9  ( F i g .  1 2 B ) .  £5/E_5 a n d  £ 5 / £ 7  c h i c k e n s  a r e  r e p r e s e n t e d  by s o l i d  a n d  d a s h e d
l i n e s ,  r e s p e c t i v e l y .  S t a n d a r d  e r r o r s  a r e  i n d i c a t e d  by  v e r t i c a l  l i n e s .
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d e v e l o p m e n t  of m e t a s t a t i c  lesions.
In a further attempt to discern possible genetic 
influences on metastasis, reciprocal crosses were made 
between B5/B5 (6-1 X 15-1)F5 and B24/B24 line 105 chickens. 
Progeny of these " F 1 ’s w , as well as progeny of the parental 
stocks, were challenged in the left wlngweb at six weeks of 
age with approximately 1200 PFU of RSV-1. Table 18 (page 
92) includes the combined data of four hatches. Sixty six 
percent of B.5/B.5 (6-1 X 15-1 )F6 chickens with terminal 
tumors had at least one histologically confirmed metastatic 
lesion. The incidence of metastasis in terminal cases from 
the other three mating types was 24$ or less. The 
reciprocal wF 1 n mating types produced similar results; thus 
maternal effects would not appear to have accounted for the 
higher incidence of metastasis observed among J2.5/B5 (6-1 X 
15 — 1)F 6 chickens. Results of chi square analysis (Table 
19A, page 93) suggest that mating type significantly 
influenced susceptibility to metastasis.
Among F2 progeny resulting from the inter se matings of 
(B5/B5 (6-1 X 15-1)F 5 X B24/B24 105)F1*s (see page 62), the 
overall incidence of histologically confirmed metastatic 
lesions associated with terminal RSV-1, RSV-2, or RSV-49 
induced tumors was low (19$)* The distribution of B5/B5, 
B5/B24, and B24/B24 chickens to presence or absence of 
confirmed metastasis is given in Table 19B (page 93). In 
this F2 population, the B5/B5 genotype is not associated 
with a high incidence of metastasis. Therefore the low
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incidence of metastasis associated with line 105 and its 
crosses appears to be the result of non-MHC genetic 
i n f l u e n c e s .
T a b l e  1 6 .  D i s t r i b u t i o n  o f  l i n e  1 0 5  c h i c k e n s  t o  p r e s e n c e  o r  a b s e n c e  o f  m e t a s t a s i s  
a c c o r d i n g  t o  B g e n o t y p e .
M e t a s t a s i s *
B g e n o t y p e
2 3 / 2 6 2 3 / 2 3 2 3 / 2 4 2 6 / 2 6 2 4 / 2 6 2 4 / 2 4
Y e s 8 1 5 8 2 3 2 0 1 9
No 2 0 3 3 2 5 7 9 5 8 4 0
X2 = 2 . 5 1 ;  P > 0 . 0 5 .
♦ A l l  c h i c k e n s  d i e d  o f  R S V -1  i n d u c e d  s a r c o m a s .  U pon  n e c r o p s y ,  a n y  s u s p e c t  l e s i o n s  w e r e  
s e c t i o n e d  a n d  p r e p a r e d  f o r  h i s t o l o g i c a l  e x a m i n a t i o n .  S i x  c a s e s  a r e  i n c l u d e d ,  h o w e v e r ,  
i n  w h i c h  p r e s e n c e  o f  m e t a s t a s i s  w a s  d e t e r m i n e d  b y  g r o s s  e x a m i n a t i o n  a l o n e .
T a b l e  1 7 A .  D i s t r i b u t i o n  o f  l i n e  1 0 5  c h i c k e n s  t o  p r e s e n c e  
o r  a b s e n c e  o f  h i s t o l o g i c a l l y  c o n f i r m e d  m e t a s t a s i s  a c c o r d i n g  
t o  l e n g t h  o f  t i m e  f r o m  i n o c u l a t i o n  w i t h  R S V - 1  t o  d e a t h .
C o n f i r m e d D a y s ( P I )  t o  d e a t h :
m e t a s t a s i s 0 - 3 0 3 1 - 4 0  4 0 - 7 0
Y e s 3 1 3 0  3 2
No 1 0 4 8 3  6 8
X2 = 2 . 4 0 ;  P > 0 . 0 5 .
C a t e g o r i e s  w e r e  c h o s e n  t o  g i v e  a p p r o x i m a t e l y  e q u a l  n u m b e r s  
i n  e a c h .
T a b l e  1 7 B .  D i s t r i b u t i o n  o f  l i n e  1 0 5  c h i c k e n s  t o  p r e s e n c e  
o r  a b s e n c e  o f  h i s t o l o g i c a l l y  c o n f i r m e d  m e t a s t a s i s  a c c o r d i n g  
t o  s e x .
C o n f i r m e d
m e t a s t a s i s
S e x :
M a l e F e m a l e
Y e s 5 0 4 3
No 1 2 1 1 3 0
X2 = 0 . 6 3 ;  P > 0 . 0 5 .
F o u r  b i r d s  w e r e  d e l e t e d  
u n k n o w n .
f r o m  t h e  a n a l y s i s b e c a u s e s e x  w a s
T a b l e  1 8 .  F r e q u e n c y  o f  m e t a s t a s i s  b y  m a t i n g  t y p e  f o r  B 5 / B 5  ( 6 - 1  x  1 5 - 1 ) F 6  a n d  
B 2 4 / B 2 4  l i n e  1 0 5  c h i c k e n s  a n d  p r o g e n y  o f  t h e  r e c i p r o c a l  i n t e r c r o s s e s .
M a t i n g
( M a l e )
t y p e
( F e m a l e )
B g e n o t y p e  
o f  p r o g e n y
N um ber
i n o c u l a t e d
Tumor  
d e v e l o p e d  
( N o . )  (%)
N o . o f
t e r m i n a l
c a s e s
Mean d a y s  
( P I )  u n t i l  
d e a t h
M e t a s t a s i s *
(%)
F5 x  F5 5 / 5 1 0 6 8 2 7 7 8 2 2 6 . 5 6 6
F5 x  1 0 5 5 / 2 4 4 0 2 9 7 2 2 6 3 1 . 4 1 9
1 0 5 x  F5 5 / 2 4 7 1 4 6 6 5 4 5 2 3 . 4 2 4
1 0 5 x  1 0 5 2 4 / 2 4 9 3 8 8 9 5 8 1 2 8 . 4 1 2
♦ P e r c e n t  m e t a s t a s i s  r e p r e s e n t s  t h e  p e r c e n t a g e  o f  t e r m i n a l  c a s e s  w i t h  a t  l e a s t  o n e  
h i s t o l o g i c a l l y  c o n f i r m e d  m e t a s t a t i c  l e s i o n .  T u m o r s  w e r e  i n d u c e d  b y  R S V - 1 .
9 3
T a b l e  1 9 A .  D i s t r i b u t i o n  b y  m a t i n g  t y p e  o f  B 5 / B 5  
( 6 - 1  x  1 5 - 1 ) F 6  a n d  B 2 4 / B 2 4  l i n e  1 0 5  c h i c k e n s  a n d  
p r o g e n y  o f  t h e  r e c i p r o c a l  i n t e r c r o s s e s  t o  p r e s e n c e  
o r  a b s e n c e  o f  h i s t o l o g i c a l l y  c o n f i r m e d  m e t a s t a s i s  
o f  R S V - 1  i n d u c e d  s a r c o m a s .
M a t i n g  t y p e  
( M a l e )  ( F e m a l e ) M e t a s t a s i s No m e t a s t a s i s
F 5  x  F5 5 4 2 8
F 5  x  1 0 5 5 2 1
1 0 5  x  F5 1 1 3 4
1 0 5  x  1 0 5 1 0 7 1
X2 = 5 8 . 2 ;  P < 0 . 0 5 .
T a b l e  1 9 B .  D i s t r i b u t i o n  o f  ( B 5 / B 5  ( 6 - 1  x  1 5 - 1 ) F 5  x  
B 2 4 / B 2 4  1 0 5 }  F 2 ' s  t o  p r e s e n c e  o r  a b s e n c e  o f  m e t a s t a s i s  
a c c o r d i n g  t o  B g e n o t y p e .
C o n f i r m e d
m e t a s t a s i s *
B g e n o t y p e :
5 / 5 5 / 2 4 2 4 / 2 4
Y e s 5 1 2 1 0
No 3 0 5 7 2 8
X2 = 1 . 9 4 ;  P > 0 . 0 5 .
♦ M e t a s t a t i c  l e s i o n s  w e r e  c o n f i r m e d  h i s t l o g i c a l l y . A l l  c a s e s  
r e p r e s e n t  t e r m i n a l  R S V - 1 ,  R S V - 2 ,  o r  R S V - 4 9  i n d u c e d  t u m o r s .
V. D I S C U S S I O N
Influence of Genetic Background on 
Anti-Sarcoma Response
RPRL inbred lines 6-1, 6 — 3» 7-2, and 100, all 
homozygous for the B2 haplotype, have differed greatly in 
response to RSV-induced sarcomas (Collins &1. 1980).
Results of studies included in this dissertation indicate 
that the observed variation between lines was the result of 
non-MHC influences rather than undetected differences within 
the M H C .
(151-5 X 7-2)F 1 chickens (B2/B15) had progressive tumor 
growth after challenge with RSV-1 in the left wing and 
RSV-49 in the right, whereas (151-5 X 6— 1)F 1 chickens 
(B2/B.15) rapidly regressed both tumors (Fig. 1A and B; page 
45). These results confirmed the findings of Marks ,e_t 
a l . ( 1979) that the incidence of tumor regression associated
with line 7-2 was low compared to that associated with lines 
6-1 and 6-3. However the cause of the variation between the
F1's, MHC or non-MHC, could not be determined since both MHC
and non-MHC variation could adequately explain the results.
That low response associated with line 7-2 was the 
result of a non-MHC influence became apparent after RSV
challenge of (151-5 X 6—3)F 1 X 7-2 chickens. Both B2/B2 and
B2/B15 chickens of this cross regressed RSV-1 and RSV-49
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i n d u c e d  sarcomas (Fig. 2A and B; page 46). B 2 / B 1 5 c h i c k e n s
received their B2 haplotype from line 7-2, and thus were 
identical at the MHC to the (151-5 X 7 - 2 ) F 1 fs of the 
previous experiment. Since the JB15 haplotype was associated 
with progressive tumor growth, as determined by (151-5 X 
6-3)F2 data (Fig. 8 A , B, and C; page 66), the high incidence 
of regression observed with B2/B15 [(151-5 X 6-3)F1 X 7-2] 
chickens was attributed to the B2 haplotype of line 7-2.
Thus a non-MHC influence associated with line 7-2 appeared 
to be capable of suppressing response against RSV-induced 
s a r c o m a s .
Assuming involvement of a. single non-MHC gene (dominant 
for high response in line 6-1 or recessive for low response 
in lines 7-2 and 151-5), approximately 50$ of the (151-5 X 
6-3)F1 X 7-2 chickens should have been characterized by 
progressive tumor growth. Only 15$ were progressors. 6-1 X 
(151-5 X 6-3)F 1 and (151-5 X 6-3)F1 X 6-3 chickens receiving 
the same RSV inoculations as the above (151-5 X 6-3)F1 X 7-2 
chickens were characterized by tumor regression more rapid 
than that observed with (151-5 X 6-3)F1 X 7-2 (Fig. 4A and 
B; page 48). These results do not support the hypothesis of 
involvement of only one non-MHC gene, but instead favor the 
involvement of multiple non-MHC loci and/or an interaction 
between an environmental variable and a non-MHC genotype.
The relative importance of non-MHC genetic background 
for anti-Rous sarcoma response was further evaluated using 
crosses of lines 100 and 105 carried to backcross and F2
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generations. B2/B23 chickens from the F1 X 105 backcross 
had a high incidence of regression of tumors induced by each 
of three different subgroups of RSV, whereas I52/B2 and 
B2/B23 chickens from the F1 X 100 backcross were 
characterized by progressive tumor growth (Fig. 5A, B, and 
C; page H 9 ) • Since B23/B23 chickens developed progressive 
tumor growth regardless of associated mating type, 
regression associated with B2/B23 chickens from the F1 X 105 
backcross was attributed to the B.2 haplotype from line 100. 
Therefore a non-MHC influence, in this case associated with 
line 100, again appeared to suppress anti-Rous sarcoma 
response. Suppression was generalized since it appeared 
regardless of RSV subgroup used.
Environmental Influences on Host Response 
to RSV-induced Sarcomas
Avian Leukosis Virus (ALV)
Congenital infection with subgroup A ALV resulted in 
increased resistance to tumor induction with RSV-1 and a 
higher incidence of tumor progression among (100 X B23/B23 
105)F1 progeny (Table 5, page 53). These results were 
consistent with previous reports (Rubin 1962, Vogt and 
Ishizaki 1966, Meyers and Qualtiere 1977).
Screening of different lines and crosses maintained at 
UNH revealed variability between lines in degree of ALV 
contamination. Lines 7-2 and C, for example, being
97
genetically resistant to subgroup A ALV, were virtually free 
of ALV contamination. Lines 151-5 and 100, on the other 
hand, being susceptible to subgroup A ALV, had high 
incidences of ALV contamination. Under conditions in which 
ALV contamination is not controlled, between line 
comparisons for anti-Rous sarcoma response could clearly be 
influenced by variability between lines in degree of ALV 
contamination. Gebriel et. aJL. ( 1979), for example, reported 
considerable variability in the tumor induction period 
following RSV-1 challenge of high and low responders to the 
amino acid polymer, GAT. GAT-high responders developed 
tumors more rapidly and had higher frequencies of tumor 
regression than GAT-low responders. The ALV status of the 
experimental chickens was not reported. Delayed tumor 
induction, low response to RSV-1 induced tumors, and 
decreased response to GAT could all result from congenital 
infections with subgroup A ALV.
Eggs from seven of eleven (6-1 X - 15— 1 )F5 dams checked 
for ALV shedding were found to be positive. Heinzelmann .gt. 
a l . (1981b) using F4 and F5 generation chickens of the 6-1 X
15-1 cross, reported cross-reactivity between the B5 
antigen(s) and RSV-induced tumor-associated antigens. 
Lymphocytes from B2/B2 chickens bearing RSV-induced tumors 
lysed normal B.5/J35 chick embryo fibroblasts (CEF), but not 
normal B2B2 CEF or normal B24/B24 cells from line 105. In
light of known ALV contamination, the observed lysis of 
"normal" B5/B5 CEF may have been the result of ALV
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c o n t a m i n a t i o n  of these cells.
Marek's Disease
Lines 151-5, 7-2, and 100 are all susceptible to 
M a r e k ’s disease (MD), whereas lines 6-1 and 6-3 are 
resistant (Altman and Katz 1979). Since MD virus is 
immunosuppressive (Jakowski j£t. jJL. 1970), highly contagious 
(Calnek and Witter 1978), and capable of suppressing 
anti-Rous sarcoma response (Calnek ££. sJL. 1 975), it is 
conceivable that the low anti-Rous sarcoma responses 
associated with the MD-susceptible lines may have been a 
result of environmental exposure to MD (in spite of MD 
v a c c i n a t i o n ) .
The higher incidence of tumor progression observed in 
one hatch of (151-5 X 6-3)F2 chickens (see Table 6A, page 
57) was associated with known exposure to M D . Histological 
examination of bursas from (151-5 X 7-2)F1 and (151-5 X 
6-3)F1 X 7-2 chickens dying with terminal tumors revealed 
cystic follicles and lymphocytic infiltration of the 
interfollicular connective tissue (Fig. 6B, page 56), 
lesions characteristic of MD (Calnek and Witter 1978).
Vaccination is known to be less effective in 
genetically susceptible stock and does not prevent 
superinfection with virulent virus (Powell 1981). In spite 
of MD vaccination of both replacement and experimental 
chickens, occasional cases of MD and increased mortality has 
been observed among MD-susceptible lines (see Table 20, page
101). Among experimental chickens, the incidence of 
clincial signs or gross lesions associated with MD has been 
low. Immunosuppression resulting from exposure to MD virus, 
however, would occur early in the course of the disease, at 
the time of virus replication in the bursa and thymus 
(Powell 1981). Thus progressive Rous sarcoma growth 
resulting from such immunosuppression could occur prior to 
development of gross MD lesions or clinical signs of M D . It 
is also conceivable that lyophilized HVT (turkey 
herpesvirus) used for MD vaccination at UNH, although 
providing at least partial protection against development of 
MD tumors, may have failed to protect susceptible chickens 
against the immunosuppressive effect of MD virus replication 
in the bursa and thymus.
Examination of the bursa and thymus from RSV-challenged 
(6-3 X 15— 1)F 4 chickens revealed that all of seventy-two 
progressors had severe atrophy of both organs (1/8 to 1/4 
normal s i z e ) , whereas the bursa and thymus of all 
seventy-nine regressors were normal (Fadly and Bacon 1979)* 
Histological examination of both bursa and thymus from the 
seventy-two progressor birds revealed atrophy of lymphoid 
follicles and pronounced connective tissue proliferation.
It was not determined whether RSV-induced tumors progressed 
because of destruction of the host's lymphoid system or 
whether the destruction was caused by the tumors. The 
normal bursa of the line 105 chicken dying of progressive 
sarcoma growth (Fig. 6A, page 56) would suggest that
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progressive Rous sarcoma growth among the (6-3 X 15-1)F4's 
reported by Fadly and Bacon was not the cause but the result 
of destruction of the h o s t ’s lymphoid system. Such 
degenerative changes in the bursa and thymus could result 
from exposure to MD virus.
Considerable variation in bursal size was found among 
16-week-old (6-1 X 1 5 - 1 )F2 chickens which had not been 
inoculated with RSV. A high incidence of bursal atrophy was 
associated with the B.5/B.5 genotype (Table 21, page 102). 
Histological evidence for MD involvement was obtained from 
sections of the atrophied bursas.
Sharma and Burmester (1982) reported that MD 
vaccination on the 18th day of embryological development 
resulted in greater resistance to subsequent challenge with 
MD virus than obtained by conventional MD vaccination at 
hatching. In an attempt to improve anti-Rous sarcoma 
response by preventing MD virus-mediated immunosuppression, 
(151-5 X 7-2)F1 and (151-5 X 6 — 1)F 1 chickens were MD 
vaccinated on the 18th day of incubation rather than at 
hatching. They were subsequently challenged at six weeks of 
age with RSV-1 and RSV-49 in the left and right wingwebs, 
respectively (Brown and DiFronzo, unpublished data).
Figures 14A and B (page 103) provide the mean tumor scores 
for the left and right wing tumors. Responses of (151-5 X
6 - 1 ) F 1 ’s was nearly identical to previous findings (see 
Figures 1A and B, page 45). (151-5 X 7 - 2 ) F 1 ’s, however,
were characterized by a lower incidence of progressive tumor
T a b l e  2 0 .  M o r t a l i t y  d a t a  o f  s o m e  r e c e n t  r e p l a c e m e n t  h a t c h e s  o f  c h i c k e n s  M D - v a c c i n a t e d  
a t  h a t c h i n g ,  U n i v e r s i t y  o f  New H a m p s h i r e  P o u l t r y  Farm
H a t c h N o . c u l l e d : * 3 N o .  d i e d :
M o r t a l ­
i t y 6
(%)
I n c i d e n c e * ^  
o f  MD 
(%)D a t e
N o .
c h i c k s 3. (M) ( F )
( N o
i n f o . )
( C a u s e
r e p o r t e d )
6 - 1 1 2 - 2 - 8 0 2 3 3 0 4 1 2 5 0
3 - 2 4 - 8 1 7 7 2 2 7 4 0 8 0
1 5 - 1 3 - 2 4 - 8 1 2 2 6 6 4 3 7 0 0
4 - 7 - 8 1 2 6 3 5 1 0 5 8 3 0
4 - 2 1 - 8 1 2 9 9 2 6 8 7 8 1 1
5 - 5 - 8 1 21 5 5 5 2 6 4 0
1 5 1 - 5 5 - 5 - 8 1 2 3 3 0 2 1 6 9 0 1 5
1 0 0 3 - 1 0 - 8 1 7 4 2 0 0 2 3 1 5 7 0 2
3 - 2 4 - 8 1 8 7 2 5 0 1 7 1 6 5 3 2
1 0 5 4 - 1 5 - 8 0 2 5 9 1 4 5 0 8 8 1 4 0
O n l y  h a t c h e s  w i t h  2 0  o r  m o r e  c h i c k e n s  a r e  s u m m a r i z e d .
^ E x c e s s  m a l e s  w e r e  c u l l e d .  F e m a l e s  w e r e  n o r m a l l y  c u l l e d  o n l y  w h e n  a f f l i c t e d  w i t h  l a m e n e s s  
o r  o t h e r  p r o b l e m s .
c M o r t a l i t y  (%) = [ ( n u m b e r  d e a d ) / ( n u m b e r  h a t c h e d  -  n u m b e r  c u l l e d ) ]  x  1 0 0
^ I n c i d e n c e  o f  MD (%) = [ ( n u m b e r  o f  c a s e s  o f  MD r e p o r t e d ) / ( n u m b e r  h a t c h e d  -  n u m b e r  
c u l l e d ) ]  x  1 0 0
1 0 2
T a b l e  2 1 .  B u r s a l  W e i g h t s  ( G r a m s )  b y  B G e n o t y p e  a n d  S e x  f o r
1 6 - W e e k - O l d  ( 6 - 1  x  1 5 - 1 )  F 2  C h i c k e n s  M D - V a c c i n -  
a t e d  a t  H a t c h i n g
B G e n o t y p e ;
2 / 2 2 / 5 5 / 5
M a l e s 1 . 8 0 0 . 2 6 l . l l b
1 . 1 8 0 . 1 6 b 0 . 4 4
0 . 3 8 0 . 2 1
0 . 3 3
F e m a l e s 1 . 7 8 2 . 3 9 0 . 7 9
1 . 6 6 1 . 6 3 0 . 7 5
1 . 2 8 0 . 2 8
x  = 1 . 1 9 a x  = 1 . 1 4 x  =  0 . 6 0
£1m e a n  o f  b o t h  s e x e s  
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growth than observed previously. Figure 15 (page 104) 
compares mean RSV-1 induced tumor scores of survivor and 
progressor (151-5 X 7-2)F1's. Variation in anti-tumor 
response cannot be explained on the basis of dosage since 
tumor size at two weeks PI is similar for both regressors 
and progressors. Regression observed among (151-5 X
7 - 2 ) F 1 ’s indicates that such chickens are capable of 
adequate anti-sarcoma response under suitable environmental 
circums t a n c e s .
Virus Subgroup
Both group and subgroup specific determinants have been 
shown to be involved in anti-Rous sarcoma response 
(Ignjatovic .ejt aJL. 1978, Hall ei ai.. 1 979). In order to 
determine whether or not the response of a given B. genotype 
to RSV-induced tumors was specific for virus subgroup, each 
of four different F2 populations were challenged with three 
subgroups of RSV (RSV-1, RSV-2, and RSV-49 of subgroups A,
B, and C, respectively).
In the three F2 populations in which the B.2 haplotype 
occurred, B2 response against RSV-1 and RSV-49 induced 
tumors was high, but response against RSV-2 induced sarcomas 
was intermediate. Lower response to RSV-2 induced sarcomas 
was not due to virus overdosage, as judged by tumor size at 
two weeks PI. The rapid regression of RSV-1 and RSV-49 
induced tumors must therefore have been due in part to high 
response against subgroup specific antigenic determinants.
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The B.15 haplotype responses to RSV-1 and RSV-2 induced 
sarcomas were relatively low, while response to RSV-49 was 
characterized by a fairly high incidence of regression, 
again suggesting subgroup specificity for anti-Rous sarcoma 
r e s p o n s e .
Three B haplotypes (15, 123, and 1.24) were 
characterized by low responses against tumors induced by 
each of the three virus subgroups. Such low responses could 
indicate inability of these haplotypes to respond to both 
group and subgroup specific antigenic determinants. 
Alternatively, the responses associated with these 1  
haplotypes may be suppressed due to exposure to an 
environmental variable such as Marek's disease. The 
characteristic MD susceptibilities of the 123 and 124 
haplotypes have not been reported. The 15 haplotype, 
however, has been shown to be susceptible to M D . Among (6-3 
X 15 — 1)F 5 chickens challenged at two weeks of age with the 
JM strain of MD virus, 60% of 15/15, 22% of 12/15, and 13? 
of 12/12 birds developed MD (Bacon el ai. 1981). Therefore, 
if MD exposure is indeed the cause of suppressed anti-tumor 
response observed among (151-5 X 7-2)F1 chickens (see 
discussion concerning possible influence of M D , page 97), 
then MD-susceptible 1  haplotypes such as 15 would be subject 
to the same immunosuppression.
Stress
The social interactions which occur among chickens in
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the formation of dominance hierarchies may result in stress 
in spite of attempts to minimize competition for food and 
water. Since physiological results of stress can manifest 
themselves in the compromise of the immune response (Monjan 
and Collector 1977)> it is conceivable that stress could 
modify anti-Rous sarcoma response.
Under the assumption that increased levels of 
corticosteroids resulting from stress may result in 
decreased anti-Rous sarcoma response, B2/B2 and B15/B15 
(151-5 X 6-3)F2 chickens were given intramuscular injections 
of dexamethasone prior to and following challenge with 
RSV-1. Anti-tumor response did not appear to be compromised 
by treatment with the corticosteroid.
The uniform anti-tumor responses observed among (151-5 
X 6— 1)F 1 chickens following RSV challenge perhaps provided 
stronger evidence that stress was not an important factor in 
anti-Rous sarcoma response. Had stress been an important 
source of variation, then a wider spectrum of responses 
should have been observed. The greater amount of within B 
genotype variation in anti-tumor response observed among F2 
generation chickens and chickens from noninbred lines could 
therefore best be explained by genetic variation and perhaps 
genetic by environmental interaction.
The observed variation in anti-sarcoma response in 
previous studies with inbred lines could reflect ALV 
contamination, exposure to MD virus, or other possible 
environmental variables. Inbred lines, on the other hand,
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could conceivably be less capable of adjusting to stressful 
conditions and therefore more subject to the resultant 
immunosuppressive effects.
Interaction of MHC Haplotypes in Relation to 
Rous Sarcoma Regression
RSV-transformed avian cells have been shown to express 
a variety of antigens relevant to the immune response 
(Ignjatovic et. si. 1 978, Hall e£ si» 1 979). Therefore, 
response against tumor cells could involve interactions with 
a wide spectrum of antigenic determinants, each contributing 
in varying degree to the observed anti-tumor response. A B 
haplotype could be characterized by high responses to some 
determinants and low responses to others. Two B haplotypes, 
each with a different characteristic spectrum of responses, 
could conceivably complement each other if some high 
responses were dominant in nature allowing such responses to 
sum across the two haplotypes. Alternatively, a hybrid 
molecule produced by heterozygotes could provide responses 
absent or greatly reduced in both parental B. types. 
Complementation for anti-Rous sarcoma response involving 
both the MHC and non-MHC genes has been reported (Cutting £t. 
Si- 1981).
Six B genotypes (three B haplotypes) of noninbred line 
UNH 105 were characterized for response to RSV-induced 
sarcomas. The B23/B26 genotype had the highest anti-tumor
]'!
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response, suggesting complementation of the B23 and B26 
haplotypes. The matings used to produce the six £. genotypes 
included some producing only one B genotype. Therefore 
non-MHC influences could account in part for the 
distribution of responses observed.
Heterozygotes carrying the B24 haplotype appeared to 
have a lower anti-tumor response than homozygotes for the 
higher responding B haplotype (either B23 or B26). This 
could be explained by an In gene dose effect similar to that 
seen with certain hybrid mice in their response to the 
synthetic terpolymer GL(j) (Dorf s£ 3i- 1 979). A B23/B23 
homozygote, having two doses of the higher responding B23 
haplotype, would thus have a greater response than a J323/B2JJ 
heterozygote carrying only one dose. An alternative 
explanation could involve cross-reactivity of B24 
alloantigens with tumor antigen(s) responsible for 
stimulating an anti-tumor response. Tolerance to the S.24 
alloantigens could result in a decreased response to the 
cross-reacting tumor antigens and lead to tumor progression. 
Several studies using various tumor systems in rats and mice 
have demonstrated such cross-reactivity (Bear s £  si. 1977» 
Parmiani et. si- 1979, Russell e£ si- 1 979 » Paciucci e_t 
a l . 1 980). Heinzelmann e£ si* (1981b), however, using 
normal B24/B24 CEF from line 105 and lymphocytes from Rous 
sarcoma bearing chickens in a cytotoxic assay found no 
evidence of cross-reactivity.
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Attempts to Localize the Non-MHC Genetic Influence 
on Rous Sarcoma Regression
Endogenous Virus, RAV-0
It was hypothesized that expression of the nondefective 
endogenous virus, RAV-0, could result in formation of a cell 
transformation-independent, nonvirion, virus group-specific 
antigen(s) similar to that described by Wainberg 
a l . (1979a) and that tolerance to such antigen could result 
in decreased ability to respond to tumors induced by avian 
leukosis or sarcoma viruses. The high incidence of tumor 
progression associated with lines 100 and 7-2, RAV-0 
producing lines homozygous for the B2 haplotype, may be 
explained on the basis of this hypothesis. The observation 
that lines 6-1 and 6-3 have high responses to RSV-induced 
sarcomas in spite of homozygosity for the defective 
chf-producing endogenous virus locus, e v - 3 . would also be 
compatible with this theory.
Experimental results did not support the hypothesis. 
(151-5 X 7-2)F1 chickens (hemizygous for e v - 2 . the locus 
coding for RAV-0) had a high incidence of tumor progression. 
In contrast, both (6-1 X 7-2)F1 (Table 14, page 83) and 
(151-5 X 6-3)F1 X 7-2 chickens (Fig. 2A and B; page 46) were 
characterized by a high incidence of tumor regression in 
spite of presence of e v - 2 . The low anti-tumor response 
associated with (151-5 X 7-2)F1's, therefore, does not 
appear to be a result of RAV-0 expression.
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Although the anti-Rous sarcoma response associated with 
the B2 haplotype does not appear to be greatly influenced by 
expression of chf or RAV-0 in the host, it should not be 
concluded that such expression would not be capable of 
suppressing anti-sarcoma responses associated with other B 
haplotypes. The B.2 haplotype may be characterized by high 
responses to subgroup specific antigenic determinants and 
thus only slightly affected by tolerance to group specific 
antigenic determinants shared by the endogenous viruses. If 
another B haplotype gave high responses against only group 
specific determinants, it might be much more affected by 
tolerance to these antigenic determinants if such tolerance 
o c c u r r e d .
An attempt was made to immunize chickens against Rous 
sarcoma challenge using the endogenous virus, RAV-0. 
Noninbred line K28 chickens were used because of the 
efficient replication of endogenous viruses in their cells 
(Robinson et. al,. 1 980). Other treatment groups included 
chickens immunized with RAV-1 (an exogenous avian leukosis 
virus), chickens immunized with chf(+) cells from line 6-1 
embryos, and control chickens inoculated with diluent alone. 
Immunization with RAV-0 did not result in enhanced 
anti-tumor responses (Fig. 12A and B, page 84). RAV-1 
immunization resulted in greater resistance to tumor 
induction with both RSV-1 and RSV-2 (Table 15, page 85) of 
subgroups A and B, respectively. Subcutaneous inoculations 
of chf(+) cells from line 6-1 appeared to result in a
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decreased rather than enhanced anti-tumor response.
The immunization results are inconclusive. Different 
routes of anti-tumor immunization have been reported to have 
contrasting results (Bauer ,e£. jil. 1979). Immunization of 
chickens and quail with lectin column-purified antigens from 
avian sarcoma virus transformed CEF resulted in tumor 
immunity if immunized intravenously and enhanced tumor 
growth if immunized intramuscularly. The choice of 
intramuscular inoculations of RAV-1 and RAV-0 was based upon 
procedures of Meyers e_fe. al. (1972) who used exogenous ALV to 
increase resistance to challenge with RSV. The choice of 
subcutaneous inoculation of line 6-1 cells was based upon 
the procedures of Parmiani and Invernizzi (1975) who used 
subcutaneous inoculations of normal kidney and liver tissue 
to induce resistance to methylcholanthrene-induced sarcomas 
in mice. Dosage of antigen used for inoculation is also 
known to influence immune responsiveness, both low and high 
doses being capable of inducing tolerance (Schwartz 1980). 
Failure to observe enhanced response in RAV-0 immunized 
chickens or in chickens immunized with 6-1 embryo tissue 
could therefore reflect a technical difficulty with the 
immunization procedures rather than a lack of 
cross-reactivity with tumor antigens involved in anti-tumor 
response.
The £  Blood-Group Locus
Lines 7-2, 100, and 151-5, all characterized by a high
ii
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incidence of progressive Rous sarcoma growth, are homozygous 
for the E.5 haplotype. Regressor lines 6-T and 6-3 are 
homozygous for E7 . Since the £  locus could possibly be 
linked to a gene affecting anti-sarcoma response, an attempt 
was made to evaluate a possible "EL locus effect” using 
(151-5 X 6-3)F1 X 7-2 chickens. No association between £  
genotype and anti-Rous sarcoma response was detected. £5/£5 
and £5/1.7 chickens regressed their RSV-induced sarcomas at 
similar rates (Fig. 13A and B, page 81).
MHC vs Non-MHC Influences on Metastasis
Metastasis is the invasion and spread of neoplastic 
cells from a primary site to distant organs (Fidler and Hart 
1978). With virus-induced tumors, secondary lesions of 
proliferating neoplastic cells could conceivably result via 
several different mechanisms:
1) Emboli of tumor cells which have detached from the 
primary tumor could circulate to small vascular beds 
of organs where they become arrested. Subsequent 
invasion of the wall of the arresting vessel and cell 
multiplication could result in metastasis (Fidler and 
Hart 1978).
2) Viremia resulting from productive virus-induced 
tumors could result in transformation of normal 
target cells at sites distant to the primary tumor.
3) The arrest of virus-producing tumor cell emboli 
could result in virus-induced transformation of 
normal surrounding tissue.
No attempt was made to identify the mechanism by which 
RSV-induced sarcomas became disseminated to distant organs.
"Metastatic” lesions were identified on the basis of
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histological appearance. Therefore it is conceivable that 
some lesions classed as metastatic may have resulted from 
v i r e m i a .
Comparisons of B5/B5 (6-1 X 15-1)F6's, B24/I24 line 
105's, and progeny of the reciprocal intercrosses following 
challenge with RSV-1 revealed a considerably higher 
frequency of metastasis among B5/B5 (6-1 X 15— 1)F 6 chickens 
than found among progeny of the other mating types (66% vs 
24$ or less). In an F2 population resulting from inter ae 
matings of [B5/B5 (6-1 X 15-1)F5 X B24/B24 105]F1's the 
B5/B5 genotype was not associated with a high incidence of 
metastasis. Therefore it appeared that a non-MHC influence 
associated with line UNH 105 could result in increased 
resistance to metastasis.
Behavior could conceivably influence frequency of 
metastasis. General manipulation of primary invasive 
neoplasms can cause the release of a shower of tumor emboli 
into the bloodstream (Fidler and Hart 1978). A chicken line 
which is highly excitable may be more susceptible to 
self-inflicted trauma during attempts to escape capture. 
Flapping of a tumor-bearing wing would clearly result in 
release of tumor emboli with the potential for metastasis. 
Line UNH 105 is a non-inbred line of New Hampshires. Lines 
6-1 and 15-1 are White Leghorn lines, and they have 
exhibited a higher degree of excitability than the heavier 
New Hampshire line. During the course of experimentation, 
behavior was not considered as a possible influence on
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frequency of metastasis. Therefore no accurate observations 
were made concerning the relative excitability of the F1 and 
F2 crosses of the New Hampshire and White Leghorn lines.
Another, perhaps more plausible hypothesis could 
involve an immunosuppressive agent such as Marek's disease 
virus. Low response to RSV-induced sarcomas could be 
specific for the tumor antigens involved. In such 
progressor birds, although T cell cytotoxic activity may be 
insufficient to control the rapidly growing tumor, other 
portions of the immune system, such as macrophages and 
natural killer (NK) cells, may be able to control 
proliferation of metastatic lesions. In contrast to the 
case of a specific immunodeficiency, low anti-sarcoma 
response could result from a generalized immunosuppression 
as can occur following exposure to MD virus. Sharma (1981) 
reported that NK activity in MD-resistant lines increased 
following exposure to MD virus, whereas NK activity in 
MD-susceptible lines decreased following such exposure. 
Chickens with progressive Rous sarcoma growth resulting from 
immunosuppression by MD virus could therefore be more 
susceptible to metastasis because of decreased NK activity.
The relative MD susceptibility of line 105 has not been 
reported, but MD has seldom been found in this line at the 
University of New Hampshire. Thus it would appear that line 
105 is fairly resistant to M D . MD resistance associated 
with the non-MHC background of line 105 could therefore 
indirectly influence susceptibility to metastasis by
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preventing MD-mediated suppression of NK activity.
Depending upon the mechanism of tumor dissemination, 
properties of the host cell itself could influence such 
spread. Relative cell susceptibility to virus infection, 
for example, would clearly influence virus dependent 
dissemination.
Chemically induced neoplasms have been found to be 
predominantly heterogeneous, each containing a variety of 
subpopulations of cells with differing metastatic potentials 
(Fidler 1978). RSV-transformed chicken fibroblasts, 
although sharing many common properties related to infection 
with RSV, can also exhibit heterogeneity. Some 
RSV-transformed avian cells, for example, are devoid of 
infectious virus (Freire and Duran-Reynals 1 953 » Rubin 1 962, 
Wainberg ejt al. 1979b). Virus devoid tumors are generally 
found under conditions of tumor regression, metastasis 
occurring only rarely. Progressive metastatic tumors, in 
contrast, are characterized by efficient virus production. 
Although the anti-tumor response of the host appears to have 
a major effect on such tumor cell heterogeneity, it is 
conceivable that the properties of the host cell prior to 
infection could influence the spectrum of cell types 
obtained following transformation.
VI. S U M M A R Y  AND C O N C L U S I O N S
Both non-MHC genetic and environmental factors were 
shown to be important sources of variation in anti-Rous 
sarcoma response. Avian leukosis virus was found to be a 
cause of both resistance to tumor induction with RSV-1 and 
increased susceptibility to progressive tumor growth. 
Exposure to Marek's disease virus was associated with a 
hatch effect on anti-tumor response. An experimental hatch 
with known exposure to MD had generally lower anti-sarcoma 
responses than subsequent hatches of the same genetic stock.
Using various crosses for evaluation of anti-sarcoma 
response, it was clearly demonstrated that low responses 
previously associated with lines 100 and 7-2 were the result 
of non-MHC genetic influences. In all cases, low anti-Rous 
sarcoma response was associated with genetic susceptibility 
to Marek's disease. Histological examination of bursas from 
chickens that had died as a result of progressive sarcoma 
growth revealed lesions characteristic of M D . Therefore low 
anti-sarcoma responses associated with MD susceptible 
chickens may have been the result of immunosuppression 
following exposure to MD virus.
Preliminary evidence of a non-MHC influence on 
susceptibility to metastasis following RSV challenge was 
obtained. The identity of the non-MHC influence(s) was not 
determined. However, decreased natural killer cell activity
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in MD— susceptible chickens exposed to MD virus would be a 
possible explanation of the high incidence of metastasis 
observed in such chickens.
An evaluation of the specificity of anti-Rous sarcoma 
response revealed that the B2 haplotype had higher responses 
against RSV-1 and RSV-49 induced sarcomas (subgroups A and 
C, respectively) than against RSV-2 induced tumors (subgroup 
B). Such subgroup specificity of anti-Rous sarcoma response 
had been previously observed by McBride si. (1981). Some 
B haplotypes were characterized by low responses to all 
three subgroups of virus induced tumors. It is plausible 
that low responses associated with these B  haplotypes may 
have resulted from genetic susceptibility and environmental 
exposure to M D .
Bacon e£ si- (1981) suggested that the high 
susceptibility of the B5 haplotype to A L V - , M D - , and 
RSV-induced tumors may be the result of a general deficiency 
in ability to control neoplastic growth. Nordskog .gt. 
a l . (1977) attributed low and high susceptibility to 
diseases in general to a "fitness" gene linked to the MHC. 
The results presented in this thesis would suggest that any 
conclusions concerning the existence of genes affecting 
general response to neoplasms or to diseases in general 
should await further experimentation under conditions in 
which exposure to immunosuppressive agents such as MD virus 
is strictly controlled. Under conditions of MD exposure, 
selection for "general fitness" may in reality be selection
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for specific resistance to M D . Genotypes with the potential 
for high resistance to other diseases could be lost in the 
selection process.
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